AU738222B2 - N-pyridonyl herbicides - Google Patents
N-pyridonyl herbicides Download PDFInfo
- Publication number
- AU738222B2 AU738222B2 AU37056/99A AU3705699A AU738222B2 AU 738222 B2 AU738222 B2 AU 738222B2 AU 37056/99 A AU37056/99 A AU 37056/99A AU 3705699 A AU3705699 A AU 3705699A AU 738222 B2 AU738222 B2 AU 738222B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- alkyl
- compounds
- compound
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Description
1-200: EP 009902313 PH15-304521A N-Pyridonyl Herbicides The present invention relates to novel, herbicidally active substituted N-pyridonyl nitrogen heterocycles, to processes for the preparation thereof, to compositions comprising those compounds, and to the use thereof in the control of weeds, especially in crops of useful plants, for example cereals, maize, rice, cotton, soybeans, rape, sorghum, sugar Icane, sugar beet sunflowers, vegetables, plantation crops and fodder plants, or in the inhibition of plant growth, and also in the non-selective control of weeds.
N-Pyridyl-pyrazoles and N-ydittaehlntizldn~n compounds having herbicidal activity are described, for example, in DE-A-3 917 469, DE-A-1 9 518 054, DE-A-1 9 530 606 and US-A-5 306 694.
N-(2-Pyridyl)-pyridazinone compounds having herbicidal activity are described, for example, in JP-A-58-213 776.
EP-A-0 500 209 discloses 1 -(2-pyridyl)pyrazoles for the control of arthropod, nematode, helminth or protozoan pests.
Novel N-pyridonyl nitrogen heterocycles having herbicidal and growth-inhibiting properties have now been found.
The present invention therefore relates to compounds of formula
I
RI
X
1
R
3 wherein R, is hydrogen, fluorine, chlorine, bromine or methyl;
R
2 is Cl-C 4 alkyl, 0 1
-C
4 haloalkyl, halogen, nitro, amino, cyano or R43 is hydrogen, 0 1 -Caalkyl,
C
3 -Csalkenyl,
C
3
-C
8 alkynyl,
C
3
-C
6 cycloalll Cl-Cshaloall, cyano-Ci-Caalkyl,
C
3 -Cshaloalkenyl, hydroxy-C-C4alk~l, Cj-C 4 aikOXY-' -C4a~yi, Crs alkenyIOXY-Cl-C4alkyl,
C
3
-C
6 alkynyloxy-Cj-C4alkl, Ci-~lk- C i-COX4alkolCclk" ClC~alkylthiO-Cl-C4lkyl, ClC 8 alkylcarbonyl, ClCakxyabnl c 3 -Ceakn, oxycarbonyl, benzyloxy-Ci- or -C 2 -allcyl, benzylcarbonYl, bezlxcr~y phenlt phenYl-C 2 -Cealkyl, benzyl, pyridyl, pyriniidinyl, pyrazinyl or pyridaziflyl, those aromatic AMENDED
SHEET
WO 99/52893 PCT/E P99/02313 -2and heteroaromatic rings being unsubstituted or mono- to tri-substituted by halogen, 0 1
-C
4 alkyl or by Cl-C 4 haloalkyl; or R44X 16 C(O)-fC 1 -C 8 alkyleneI-
R
43 is R4,X 16 C(Q)-Cl-C 8 alkyl- orI
(CAH)
Xjr 6 is oxygen, sulfur or is hydrogen, 0 1
-C
8 alkyl, C 3
-C
8 alkenyl, C 3
-C
8 alkynyl, C 3
-C
6 CYCloalkyl, Cl-C 8 haloalkyl,
C
3
-C
8 haloalkenyl, C 1
-C
4 alkoxy-C 1
-C
4 alkyl, C 3
-C
6 alkenyloxy-Cj-C 4 alkyl, C 1
-C
4 alkylthio-C 1
C
4 alkyl, phenyl, phenyl mono- to tni-substituted by halogen, C 1
-C
4 alkyl or by Cl-C 4 -haloalkyl, benzyl or benzyl mono- to tni-substituted on the phenyl ring by halogen, CI-C 4 alkyl or by CI-C 4 haloalkyl;
R
45 is hydrogen, CI-C 8 alkyl, C 3 -C~alkenyl, C 3 -Csalkynyl, 0 3
-C
6 CYCloalkyl, Cl-C 8 haloalkyl or benzyl;
R
3 is hydroxy, Cl-C 6 alkoxy, C 3
-C
6 alkenyloxy, C 3
-C
6 alkynyloxy, Cl-C 6 haloalkoxy, C 3
-C
6 haloalkenyloxy, C, -C~alkoxy-C, -C~alkyl, C 3 -Csalkenyloxy-Cl-C 6 alkyl, C3-C 6 alkynyloxy-
C
1
-C
6 alkyl, Cl-C 6 alkoxy-C, -C 6 alkoxy-Cl-C 6 alkyl, B, -Cl -C 6 alkoxy, R4(R 5 C, -C 6 alkyl,
C
3
-C
6 alkenyl, C 3
-C
6 alkynyl, C 2
-C
6 haloalkyl, C 3
-C
6 haloalkenyl, C 3
-C
6 CYCioalkyl, C 3
-C
6 halocycloalkyl, B, -C 6 alkyl, OHO-, C 1
-C
6 alkylcarbonyl, Cl-C 6 alkylcarbonyloxy, C, -C 6 haloalkylcarbonyl, C 2
-C
6 alkenylcarbonyl, C, -C 6 alkoxycarbonyl, C, -C 6 alkyl-S(O) 2 C, -C 6 haloalkyl-S(O) 2
C
3
-C
8 trialkylsilyloxy, (C1-C 6 alkyI) 2 N-N=CH-, CH 2 C C 3 alkyj B, (CH 3 2 N-CH=N-, -C 5 hydroxyalkyl)-CH 2 (B,-Cl-C 5
CH-
hydroxyalkyl)-CH 2
-C
5 haloalkyl)-CH 2 (hydroxy-Cl-C 5 alkyl)-O- or (B 1 -Cl-C 5 hydroxyalkyl)-O-*, B, is cyano, OHC-, HOC(O)-, Cl-C 6 alkylcarbonyl, C 1
-C
6 haloalkylcarbonyl, C1-C 6 alkoxycarbonyl, C 3
-C
6 alkenyloxycarbonyl, C 3
-C
6 alkynyloxycarbonyl, benzyloxy, benzyloxycarbonyl, benzyloxycarbonyl mono- to tni-substituted on the phenyl ring by halogen, C1-C 4 alkyl or by Cl-C 4 haloalkyl, benzylthio, benzylthiocarbonyl, benzylthiocarbonyl mono- to tni-substituted on the phenyl ring by halogen, C1-C 4 alkyl or by Cl-C 4 haloalkyl, Cl-C 6 haloalkoxycarbonyl, Cl-C 6 alkylthio-C(o)., R 6
(R
7 phenyl, phenyl mono- to WO 99/52893 PCT/EP99/02313 -3tni-substituted by halogen, C 1
-C
4 alkyl or by Cl-C 4 haloalkyl, 0 1
-C
6 alkyl-S(O) 2
C
1
-C
6 alkyl-S(O)-, 0 1
-C
6 alkylthio-, 0 3
-C
6 CYCloalkyl, C 1
-C
6 alkoxy, C 3
-C
6 alkenylthio or C3-C6alkynylthio;
R
4 and R 5 are each independently of the other hydrogen, Cl-C 6 alkyl, C 3
-C
6 alkenyl, C 3
-C
6 alkynyl, C 1
-C
6 haloalkyl, C 3
-C
6 haloalkenyl, C 3
-C
6 CYCioalkyi, C 1 -C~alkoxy-C, -C~alkyl, OHO-, Cl -C 6 alkyicarbonyl, Cl -C 6 haloalkylcarbonyl,
C
1
-C
6 alkyl-S(O) 2 or Cl-C 6 haloalkyl-
R
6 and R 7 are each independently of the other hydrogen, Cl-C 6 alkyI, C 3
-C
6 alkenyl, C 3
-C
6 alkynyl, Cl-C 6 haloalkyl, C 3
-C
6 haloalkenyl, phenyl, phenyl mono- to tni-substituted by halogen, C 1
-C
4 alkyl or by Cl-C 4 haioalkyl, benzyl or benzyl mono- to tni-substituted on the phenyl ring by halogen, C 1
-C
4 alkyl or by Cl-C 4 haloalkyl; X, is oxygen or sulfur; R9 R 12 R w is agroup N"8(Wi), I (W 2
NW)
N NN R 1 4 X 3 N X 2
X
4
N
IR
18
R
21 R2 22 2 6 R 5 (W4)
(W
6 \N R2(W)
X
6
NX
0 N X9 N R 17
X
8 N X
R
28 R27 R R2 R 31 a (W 8 (V N/R9
X
1 2 N X 1 1 N,3 l N X 1
R
8 is Cl-C 3 alkyl, Cl-C 3 haloalkyl or amino;
R
9 is Cl-C 3 haloalkyl, Cj-C 3 alkyi-S(O),, 1 Ci-C 3 haloalky-S(O)nl or cyano; or
R
8 and R 9 together form a 03- or C 4 -alkylene bridge or C3Y or C 4 -alkenylene bridge, each of which may be substituted by halogen, Cl-C 3 haloalkyl or by cyano; nj is0,lor 2; Rio is hydrogen, Cl-C 3 alkyl, halogen, Cl-C 3 haloalkyl or cyano; or WO 99/52893 PCT/EP99/02313 -4- Rio and R 9 together form a 03- or C 4 -alkylene bridge or C3- or C 4 -alkenylene bridge, each of which may be substituted by halogen, 0 1
-C
3 haioalkyl or by cyano; Ril is hydrogen, CI-C 3 alkyl, halogen or cyano;
R
12 is Cl-C 3 haloalkyl;
R
12 and Ril together form a C3- or C 4 -alkylene bridge or 03- or C 4 -alkenylene bridge;
R
13 is hydrogen, 0 1
-C
3 alkyl or halogen;
R
13 and R 12 together form a 03- or C 4 -alkylene bridge or 03- or C 4 -alkenylene bridge;
R
14 is hydrogen, Cl-C 3 alkyI, halogen, 0 1
-C
3 haloalkyl, R 33 R34S(0)n 2
R
35
(R
36
)N,
R
38
(R
39
)N-C(R
37 hydroxy, nitro or N= 0-S-;
R
33 is Cl-C 3 alkyl, Cl-C 3 haloalkyl, 0 2
-C
4 alkenyl, 03- or 0 4 -alkynyl or Cl-C 5 alkoxycarbonyl- Cl-C 4 alkyl; R34 is C 1
-C
4 alkyl or Cl-C 4 haloalkyl; n 2 isO0,l1or 2;
R
35 is hydrogen, 0 1
-C
4 alkyl, Cl-C 4 haloalkyl, C 3
-C
6 cycloalkyl, OHO- or Cl-C 4 alkylcarbonyl;
R
36
R
37 and R 39 are each independently of the others hydrogen or 0 1
-C
4 alkyl;
R
38 is 0 1
-C
4 alkyl;
R
1 5 is hydrogen, 0 1
-C
4 alkyl, halogen, Cl-C 4 haloalkyl, C 2
-O
4 alkenyi, C 3
-C
5 haloalkenyl, C3or 0 4 -alkynyl, Cl -C 4 alkoxy, C 1
-C
4 alkylcarbonyi, Cl -C 4 haloalkylcarbonyl, C 2
-C
4 alkenylcarbonyl, C2-C 4 haloalkenylcarbonyl, 0 2
-C
4 alkynylcarbony, C 2
-C
4 haloalkynylcarbonyl, Cl -O4alkoxycarbonyl, Cl -C 4 alkylcarbamoyl, Cl-0 4 alkyIS(0)n 3 03- or C 4 -alkynyIS(0)n 3 OHO-, nitro, amino, cyano or NE=C-Sn 3 isQ0,l1or 2; Rir, and R 17 are each independently of the other hydrogen, Cl-C 4 alkyl, halogen, 0 1
-C
4 haloalkyl or cyano;
R
18 and Rig are each independently of the other hydrogen, methyl, halogen, hydroxy or =0;
R
20 and R 21 are each independently of the other hydrogen, C 1
-O
4 alkyl or Ci-C 4 haloalkyl;
R
22 and R 23 are each independently of the other hydrogen, Cl-C 3 alkyl, halogen or hydroxy;
R
24 and R 2 s are each independently of the other hydrogen or 0 1
-C
4 alkyl; or /R4
R
24 and R 25 together form the group =C,
R
40 and R 41 are each independently of the other 0 1
-C
4 alkyl; or WO 99/52893 PCTIEP99/02313
R
40 and R 41 together form a 04- or 0 5 -alkylene bridge;
R
26 is hydrogen or Cl-C 3 alkyl or
R
26 together with R 25 forms a 0 3
-C
5 alkylene bridge, which may be interrupted by oxygen and/or substituted by halogen, Cl -C 4 alkyl, 0 2
-C
4 alkenyl, 0 1
-C
3 haloalkyl, Cl -C 3 alkylcarbonyloxy, 0 1
-C
4 alkoxycarbonyl, 0 1
-C
3 alkylsulfonyloxy, hydroxy or by =0;
R
27
R
28
R
29 and R 30 are each independently of the others hydrogen, 0 1
-C
3 alkyI, C3- or C4alkenyl or C 3
-C
5 alkynyl; or
R
27 and R 28 together and/or R 29 and R 30 together in each case form a C 2
-C
5 alkylene bridge or 0 3
-C
5 alkenylene bridge, each of which may be interrupted by oxygen, sulfur or S(0) 2 and/or substituted by halogen, Cl-C 4 alkyI, 0 2
-C
4 alkenyl, C 1
-C
3 alkylcarbonyloxy,
C
1
-C
3 alkylsulfonyloxy, hydroxy or by =0;
R
3 1 is hydrogen, C 1
-C
4 alkyl, 0 1
-C
4 haloalkyl, C3- or C 4 -alkenyl, CF~ or C,-haloalkenyl or CF~ or 0 4 -alkynyl;
R
32 is hydrogen, 0 1
-C
4 alkyl, Cl-C 3 aikoxy-0 1 or -0 2 -alkyl, Cl-C 4 haloalkyl, 03F or C 4 -alkenyl, 03F or C 4 -haloalkenyl or 03- or C 4 -alkynyl; or
R
32 and R 31 together form a C 3
-C
5 alkylene bridge; and
X
2
X
3
X
4
X
5
X
6
X
7
X
8
X
9
X
10
X
1 I, X 12
X
13
X
1 4 and X 15 are each independently of the others oxygen or sulfur, and the agrochemically acceptable salts and stereoisomers of those compounds of formula 1.
In the above definitions, halogen is to be understood as being iodine or, preferably, fluorine, chlorine or bromine.
The alkyl, alkenyl and alkynyl groups in the substituent definitions may be straight-chain or branched, this applying also to the alkyl, alkenyl and alkynyl moiety of the following groups: alkylcarbonyl, alkenylcarbonyl, alkynylcarbonyl, hydroxyalkyl, cyanoalkyl, alkoxyalkyl, alkoxyalkoxyalkyl, alkylthio, alkenylthio, alkynylthio, alkylthio-C(O)-, alkylsulfinyl, alkylsulfonyl, alkylaminocarbonyl, dial kyla minoca rbonyl, (alkyl) 2 N-N=CH-, alkylcarbamoyl, trialkylsilyloxy, B 1 -alkyl and HOC(0)-alkyl.
Alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl and the various isomeric pentyl and hexyl radicals. Methyl, ethyl, n-propyl, isopropyl and n-butyl are preferred.
Examples of alkenyl radicals that may be mentioned are vinyl, allyl, methallyl, 1 -methylvinyl, but-2-en-1-yl, pentenyl and 2-hexenyl, with preference being given to alkenyl radicals WO 99/52893 PCT/E P99/02313 -6having a chain length of from 3 to 5 carbon atoms.
Examples of alkynyl radicals that may be mentioned are ethynyl, propargyl, 1-methylpropargyl, 3-butynyl, but-2-yn-1-yl, 2-methylbutyn-2-yl, but-3-yn-2-yl, 1-pentynyl, pent-4-yn- 1-yl and 2-hexynyl, with preference being given to alkynyl radicals having a chain length of from 2 to 4 carbon atoms.
Suitable haloalkyl radicals are alkyl groups that are mono- or poly-substituted, especially mono- to tri-substituted, by halogen, halogen being in particular iodine or especially fluorine, chlorine or bromine, for example fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2-chloroethyl, 2,2-dichloroethyl, 2,2,2-trifluoroethyl, 2,2,2-trichloroethyl and pentafluoroethyl.
Suitable haloalkenyl radicals are alkenyl groups mono- or poly-substituted by halogen, halogen being in particular bromine, iodine or especially fluorine or chlorine, for example 2or 3-fluoropropenyl, 2- or 3-chloropropenyl, 2- or 3-bromopropenyl, 2,3,3-trifluoropropenyl, 2,3,3-trichloropropenyl, 4,4,4-trifluorobut-2-en-1 -yl and 4,4,4-trichlorobut-2-en-1 -yl. Of the alkenyl radicals mono-, di- or tri-substituted by halogen, preference is given to those having a chain length of 3 or 4 carbon atoms. The alkenyl groups may be substituted by halogen at saturated or unsaturated carbon atoms.
Suitable haloalkynyl radicals are, for example, alkynyl groups mono- or poly-substituted by halogen, halogen being bromine, iodine or especially fluorine or chlorine, for example 3fluoropropynyl, 3-chloropropynyl, 3-bromopropynyl, 3,3,3-trifluoropropynyl and 4,4,4trifluoro-but-2-yn-1 -yl.
Alkylthio is, for example, methylthio, ethylthio, propylthio or butylthio or a branched isomer thereof.
Alkylsulfonyl is, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl, tert-butylsulfonyl or an isomer of pentylsulfonyl or hexylsulfonyl; preferably methylsulfonyl or ethylsulfonyl.
Haloalkylsulfonyl is, for example, fluoromethylsulfonyl, difluoromethylsulfonyl, trifluoromethylsulfonyl, chloromethylsulfonyl, trichloromethylsulfonyl, 2-fluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl or 2,2,2-trichloroethylsulfonyl.
Cyanoalkyl is, for example, cyanomethyl, cyanoethyl, cyanoeth-1-yl or cyanopropyl.
Hydroxyalkyl is, for example, hydroxymethyl, 2-hydroxyethyl or 3-hydroxypropyl.
Alkylamino is, for example, methylamino, ethylamino or an isomer of propylamino or butylamino.
WO 99/52893 PCT/EP99/02313 -7- Dialkylamino is, for example, dimethylamino, diethylamino or an isomer of dipropylamino or dibutylamino.
Alkenylamino is, for example, allylamino, methallylamino or but-2-en-1 -ylamino.
Alkynylamino is, for example, propargylamino or 1 -methylpropargylamino.
Haloalkylamino is, for example, chioroethylamino, trifluoroethylamino or 3-chioropropylamino.
Di(haloalkyl)amino is, for example, di(2-chloroethyl)amino.
Alkylcarbonyl is especially acetyl or propionyl.
Haloalkylcarbonyl is especially trifluoroacetyl, trichloroacetyl, 3,3,3-trifluoropropionyl or 3,3,3-trichloropropionyl.
Alkenylcarbonyl is especially vinylcarbonyl, allylcarbonyl, methallylcarbonyl, but-2-en-1 ylcarbonyl, pentenylcarbonyl or 2-hexenylcarbonyl.
Alkynylcarbonyl is especially acetylenecarbonyl, propargylcarbonyl, 1 -methylpropargylcarbonyl, 3-butynylcarbonyl, but-2-yn-1 -ylcarbonyl or pent-4-yn-1 -ylcarbonyl.
Alkoxy is, for example, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, secbutoxy, tert-butoxy or an isomer of pentyloxy or hexyloxy.
Alkenyloxy is, for example, allyloxy, methallyloxy or but-2-en-1 -yloxy.
Alkynyloxy is, for example, propargyloxy or 1 -methylpropargyloxy.
Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-p ropoxym ethyl, n-propoxyethyl, isopropoxymethyl or isop ropoxyethyl.
Alkenyloxyalkyl is, for example, allyloxyalkyl, methallyloxyalkyl or but-2-en-1 -yloxyalkyl.
Alkynyloxyalkyl is, for example, propargyloxyalkyl or 1 -methylpropargyloxyalkyl.
Alkoxycarbonyl is, for example, methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl or n-butoxycarbonyl, preferably methoxycarbonyl or ethoxycarbonyl.
Alkenyloxycarbonyl is, for example, allyloxycarbonyl, methallyloxycarbonyl, but-2-en-1 yloxycarbonyl, pentenyloxycarbonyl or 2-hexenyloxycarbonyl.
Alkynyloxycarbonyl is, for example, propargyloxycarbonyl, 3-butynyloxycarbonyl, but-2-yn-1yloxycarbonyl or 2-methylbutyn-2-yloxycarbonyl.
Haloalkoxy is, for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 1,1 ,2,2-tetrafluoroethoxy, 2-f luoroethoxy, 2-chloroethoxy or 2,2,2-trichloroethoxy.
Suitable haloalkenyloxy radicals are alkenyloxy groups mono- or poly-substituted by halogen, halogen being in particular bromine, iodine or especially fluorine or chlorine, for example 2- or 3-f luoropropenyloxy, 2- or 3 -chloropropenyloxy, 2- or 3-bromop rope nyloxy, 2 ,3,3-trifluoropropenyloxy, 2,3,3-trichloropropenylo,y 4,4,4-trifluoro-but-2-en-1 -yloxy or WO 99/52893 PCT/EP99/02313 4,4,4-trichlorobut-2-en-1 -yloxy.
The cycloalkyl radicals suitable as substituents are, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
The halocycloalkyl radicals suitable as substituents are, for example, mono-, di- or up to per-halogenated cycloalkyl radicals, for example fluorocyclopropyl, chlorocyclopropyl, bromocyclopropyl, 2,2-dichlorocyclopropyl, 2,2-difluorocyclopropyl, 2,2-dibromocyclopropyl, 2 -fluoro-2-chlorocyclopropyl, 2-chloro-2-bromocyclopropyl, 2,2,3,3-tetrafluorocyclopropyl, 2 ,2,3,3-tetrachlorocyclopropyl, pentafluorocyclopropyl, fluorocyclobutyl, chlorocyclobutyl, 2,2-difluorocyclobutyl, 2,2,3,3-tetrafluorocyclobutyl, 2,2,3-trifiuoro-3-chlorocyclobutyl, 2,2dichloro-3,3-difluorocyclobutyl, fluorocyclopentyl, difluorocyclopentyl, chlorocyclopentyl, perfluorocyclopentyl, chlorocyclohexyl and pentachiorocyclohexyl.
Corresponding meanings may also be given to the substituents in combined definitions, such as, for example, alkylcarbonyloxy, alkoxyalkoxyalkyl, alkoxycarbonylalkyt, haloalkoxycarbonyl, haloalkylcarbonyl, haloalkenylcarbonyl, haloalkynylcarbonyl, alkylthio-C(O)-, alkenylthio, alkynylthio, alkyl-S(O)-, alkylsulfonyloxy, R 33 R4(Rs)N-, R 35
(R
36
R
6
(R
7
R
38
(R
39
)N-C(R
37 R34S(O)r, 2 B3 1 -alkyl, B3 1 -alkoxy, B 1
(B
1 -haloalkyl)-
CH
2 and (B 1 -hydroxyalkyl)-CH 2 In the definition of R 3 (Cl-C 5 hydroxyalkyl)-CH 2
(B
1 -Cl-C 5 hydroxyalkyl)-CH 2 and (Bi-Cj-C 5 haloakyl)-CH 2 signify that only the C 1
-C
5 alkyl moiety is hydroxylated or halogenated, that is to say the methylene group is not hydroxylated or halogenated.
L in the reagents of formulae VI, XI, XIX, XXVIII, XXXIa, XXXIb and XXXXII denotes a leaving group, such as, for example, halogen, preferably chlorine, bromine or iodine,
C
1
-C
3 alkyl- or aryl-sulfonyloxy, preferably CH 3
SO
2 O- or CH 3 -&/so 2 o- or Cl-C6alkylcarbonyloxy, preferably acetyloxy.
L, in the reagent of formula XX denotes a leaving group, such as, for example, HOS(O) 2 0-, N0 2
OH
3 NO 2 -6 0 or H 3 C /OS(O) 2
OH
3
L
2 in the reagents of formulae XXXIla and XXXIIc denotes a leaving group, such as, for example, hydroxy, Cl-C 4 alkoxy or halogen, preferably chlorine, bromine or iodine.
WO 99/52893 PCT/EP99/02313 -9-
L
3 in the reagent of formula XXXVIII denotes a leaving group, such as, for example, chlorine or bromine, trichloromethoxy or -N In the definitions of cyanoalkyl, alkylcarbonyl, alkylcarbonyloxy, alkenylcarbonyl, haloalkenylcarbonyl, alkynylcarbonyl, alkoxycarbonyl, alkylthiocarbonyl and haloalkylcarbonyl, the upper and lower limits of the number of carbon atoms given in each case do not include the cyano or carbonyl carbon atom, as the case may be.
The invention relates also to the salts that the compounds of formula I having azide hydrogen, especially the derivatives with carboxylic acid and sulfonamide groups (e.g.
carboxyl-substituted alkyl and alkoxy groups and alkyl-S(O) 2 NH and haloalkyl-S(O) 2
NH
groups) are able to form with bases. Those salts are, for example, alkali metal salts, e.g.
sodium and potassium salts; alkaline earth metal salts, e.g. calcium and magnesium salts; ammonium salts, that is to say unsubstituted ammonium salts and mono- or poly-substituted ammonium salts, e.g. triethylammonium and methylammonium salts; or salts with other organic bases.
Among the alkali metal and alkaline earth metal hydroxides as salt formers, attention is drawn, for example, to the hydroxides of lithium, sodium, potassium, magnesium and calcium, but especially to the hydroxides of sodium and potassium. Suitable salt formers are described, for example, in WO 97/41112.
Examples of amines suitable for ammonium salt formation include ammonia as well as primary, secondary and tertiary C 1 -Cisalkylamines, C,-C 4 hydroxyalkylamines and C 2
-C
4 alkoxyalkylamines, for example methylamine, ethylamine, n-propylamine, isopropylamine, the four isomers of butylamine, n-amylamine, isoamylamine, hexylamine, heptylamine, octylamine, nonylamine, decylamine, pentadecylamine, hexadecylamine, heptadecylamine, octadecylamine, methylethylamine, methylisopropylamine, methylhexylamine, methylnonylamine, methylpentadecylamine, methyloctadecylamine, ethylbutylamine, ethylheptylamine, ethyloctylamine, hexylheptylamine, hexyloctylamine, dimethylamine, diethylamine, di-npropylamine, diisopropylamine, di-n-butylamine, di-n-amylamine, diisoamylamine, dihexylamine, diheptylamine, dioctylamine, ethanolamine, n-propanolamine, isopropanolamine, N,N-diethanolamine, N-ethylpropanolamine, N-butylethanolamine, allylamine, n-butenyl-2-amine, n-pentenyl-2-amine, 2 3 -dimethylbutenyl-2-amine, dibutenyl-2-amine, n-hexenyl-2-amine, propylenediamine, trimethylamine, triethylamine, tri-n-propylamine, triisopropylamine, tri-n-butylamine, triisobutylamine, tri-sec-butylamine, tri-n-amylamine, WO 99/52893 PCTIEP99/02313 methoxyethylamine and ethoxyethylamine; heterocyclic amines, for example pyridine, quinoline, isoquinoline, morpholine, thiomorpholine, piperidine, pyrrolidine, indoline, quinuclidine and azepine; primary arylamines, for example anilines, methoxyanilines, ethoxyanilines, m- and p-toluidines, phenylenediamines, benzidines, naphthylamines and m- and p-chloroanilines; but especially triethylamine, isopropylamine and diisopropylamine.
The salts of compounds of formula I having basic groups, especially having basic pyrazolyl rings (W 3 W4), or the derivatives with amino groups, for example alkylamino and dialkylamino groups, in the definition of R 3 Re or R 1 4 are, for example, salts with inorganic or organic acids, for example hydrohalic acids, such as hydrofluoric acid, hydrochloric acid, hydrobromic acid or hydriodic acid, and also sulfuric acid, phosphoric acid and nitric acid, and organic acids, such as acetic acid, trifluoroacetic acid, trichloroacetic acid, propionic acid, glycolic acid, thiocyanic acid, citric acid, benzoic acid, oxalic acid, formic acid, benzenesulfonic acid, p-toluenesulfonic acid and methanesulfonic acid.
The presence of an asymmetric carbon atom in the compounds of formula I, e.g. in the substituent R 3 where R 3 is a branched alkyl, alkenyl, haloalkyl or alkoxyalkyl group or R 3 is
(B
1
-C
1
-C
5 hydroxyalkyl)-CH 2 wherein e.g. B 1 is C 1
-C
6 alkyl-S(O)-, means that the compounds may be in the form of optically active individual isomers or in the form of racemic mixtures. In the present invention, "compounds of formula I" is to be understood as including both the pure optical antipodes and the racemates or diastereoisomers.
When an aliphatic C=C or C=N-O double bond (syn/anti) is present, geometric isomerism may occur. The present invention relates to those isomers also.
Preference is given to compounds of formula 0l
R
1
R
2
N
X,
R
3 wherein
R
1 is hydrogen, fluorine, chlorine, bromine or methyl; R 2 is methyl, halogen, hydroxy, nitro, amino or cyano; and R 3 X, and W are as defined for formula I.
WO 99/52893 PCT/E P99/02313 -11 Preference is also given to compounds of formula I wherein W is the group RNR9
X
3 Nq and R 8
R
9 Rio, X 2 and X 3 are as defined for formula I. Of those compounds, special preference is given to those wherein R 8 is methyl; R 9 is trifluoromethyl; Rio is hydrogen; and X 2 and X 3 are oxygen.
Also preferred are compounds of formula I wherein W is a group
/R
3 1
(W
7 or and R 11
R
1 2
R
13
R
24
R
25
R
26
R
31
R
32
X
4 Xg, Xio and X 1 5 are as defined for formula I.
Preferred compounds of formula I are those wherein W is a group R19
R
18 I N
R
17
R
2 1
R
2 0 (W5), X, N
I
R
23 S N R22
I
(W
6 or
N-N
12 1 11~ and R 1 4
R
15
R
16
R
17
R
1
R
19
R
2 0
R
21
R
2 2
R
2 3
R
27
R
28 Xs, X 6
X
7 Xa, X 11 and X 12 are as defined for formula I.
Also preferred are compounds of formula I wherein R 1 is hydrogen, fluorine or chlorine; R 2 is chlorine, bromine, cyano or CF 3 and X, is oxygen.
Of those compounds, special preference is given to those wherein R 1 is fluorine or chlorine; and R 2 is chlorine, bromine or cyano, and of those compounds special importance is attached to those wherein R 1 is fluorine; and R 2 is chlorine.
WO 99/52893 PCT/E P99/02313 -12- The process according to the invention for the preparation of compounds of formula I R1 R 2 W (1)
N
X,
R
3 wherein R 1
R
2 and W are as defined for formula I; X, is O or S; R 3 is C 1
-C
6 alkoxy-C 1
-C
6 alkyl, C1-C 6 alkoxy-C1-C 6 alkoxy-C-Cealkyl, C 1
-C
6 alkyl, C 3
-C
6 alkenyl, C3-C 6 alkynyl, C2-C6haloalkyl, C3-C 6 haloalkenyl, C3-C6cycloalkyl, C3-C 6 halocycloalkyl, B,-C,-C 6 alkyl, 1>-CH 2 0
CC
3 alkyl (C 1 -Cshydroxyalkyl)-CH 2
(B
1
-C
1 -Cshydroxyalkyl)-CH 2 or
SCH,-
(B
1 -C,-Cshaloalkyl)-CH 2 and B, is as defined for formula I is carried out analogously to known procedures, for example as described in CH Application No. 695/97 and references given therein, and comprises oxidising a compound of formula III
R,
R
2 w
N
for example with hydrogen peroxide/urea adduct in the presence of a carboxylic acid and/or a carboxylic acid anhydride, organic peracid or persulfonic acid (Caro's acid) in a suitable solvent, to form a compound of formula V
R,
2- W
(V)
\O
0' and then rearranging that compound in an inert solvent in the presence of an anhydride or in the presence of antimony pentachloride (Katada reaction) to yield, after aqueous working-up and purification, a compound of formula II WO 99/52893 PCT/EP99/02313 -13-
R,
R
2 W (ll),
N
OH
the radicals R 1
R
2 and W in the compounds of formulae II, III and V being as defined, and then alkylating that compound in the presence of an inert solvent and a base with a compound of formula VI
R
3 -L
(VI),
wherein R 3 is as defined and L is a leaving group, preferably chlorine, bromine, iodine,
CH
3
SO
2 0- or cH 3 soo- in a suitable inert solvent and a base to form the isomeric compounds of formulae I and IV Ri
R,
R W and R 2 W (IV), N
N
X, R 3 OR 3 wherein R 1
R
2 Ra and W are as defined and X 1 is 0, and then, after the compound of formula I has been separated from the pyridol derivative of formula IV, optionally functionalising the pyridono derivative of formula I further in accordance with the definition of X, and R 3 for example with the aid of a suitable sulfur reagent to form the corresponding pyridinethione derivative (Xi S).
When R 3 in the pyridol derivative of formula IV is an allyl group or a homolog thereof (R 3
C
3
-C
6 allyl group), those pyridol derivatives of formula IVb in Reaction Scheme 1 may be rearranged in a manner analogous to that described, for example, in J. Org. Chem. 50, 764 (1985) and Tetrahedron Lett. 1979, 3949, in the presence of a suitable catalyst, for example palladium(ll) chloride/diacetonitrile or palladium(ll) chloride/phenylacetonitrile complex, to form the isomeric N-allylated pyridone derivative of formula I (R 3
C
3
-C
6 allyl group).
That rearrangement reaction is illustrated in Reaction Scheme 1 below.
Reaction Scheme 1: WO 99/52893 PCT/EP99/02313 -14- Ri catalyst, e.g.
R,
2 PdCI2(CH3CN)2 2-
R
2 /W R W N -solvent N
N
O-C
3 -Callyl group X, R IVb I R =C 3
-C
6 allyl group) The compounds of formula I wherein R 1
R
2 and W are as defined for formula I, X, is oxygen and R 3 is C1-C 6 alkyl, C 3
-C
6 alkenyl, Cs-C 6 alkynyl, C 2
-C
6 haloalkyl or C 3
-C
6 haloalkenyl may be obtained in a manner analogous to that described in J. Org. Chem. 38, 3268 (1973), ibid 16, 1143 (1951), Chem. Communic. 1979, 552 or J. Am. Chem. Soc. 78, 416 (1956) from the compounds of formula IVa
R
2 W (IVa),
N
R
0 3 wherein R 1
R
2 and W are as defined for formula I and R 0 3 is a lower alkoxy group, e.g. C1or C 2 -alkoxy, benzyloxy or halogen, e.g. chlorine or bromine, by first reacting a compound of formula IVa with an alkylating agent of formula VI
R
3 -L (VI), wherein R 3 is C 1
-C
6 alkyl, C 3
-C
6 alkenyl, C 3
-C
6 alkynyl, Cz-C 6 haloalkyl or C 3
-C
6 haloalkenyl and L is a leaving group, and then either heating or treating with dimethyl sulfoxide, if appropriate in the presence of an alkali metal halide, or with iodine or hydrochloric acid.
The compounds of formula I wherein R 1
R
2 and W are as defined for formula I, X, is oxygen and R 3 is C 1 -Calk alkenyl, C-Ckny, C 3 -Calkynyl, C 2
-C
6 haloalkyl, C 3
-C
6 haloalkenyl or
C
3
-C
6 cycloalkyl may, in a further synthesis variant, be obtained in a manner analogous to that described in Heterocycles 45, 1059 (1997) or Chem. Pharm. Bull. 2, 193 (1954) from the compounds of formula III R1
R
2 W l iN wherein R 2 and W are as defined, by reaction with an alkylating reagent of formula VI WO 99/52893 PCT/EP99/02313
R
3 -L (VI), wherein R 3 is C 1
-C
6 alkyl, C 3
-C
6 alkenyl, C 3
-C
6 alkynyl, 0 2
-C
6 haloalkyl, C 3
-C
6 haloalkenyl or
C
3
-C
6 cycloalkyl and L is a leaving group, and with an oxidising agent, for example manganese dioxide (MnO 2 or potassium hexacyanoferrate (K 3 Fe(CN) 6 The process according to the invention for the preparation of compounds of formula I Ri R W (I)
N
X1 R3 wherein R 1
R
2 and W are as defined for formula I; X 1 is S; R 3 is hydroxy, C 1
-C
6 alkoxy,
C
3
-C
6 alkenyloxy, C 3
-C
6 alkynyloxy, C 1
-C
6 haloalkoxy, C 3
-C
6 haloalkenyloxy, B 1
-C
1
-C
6 alkoxy, C -C 6 alkylcarbonyloxy, C 3 -Catrialkylsilyloxy, (hydroxy-C 1
-C
5 alkyl)-O- or (B 1
-C-C
5 hydroxyalkyl)-O-; and B 1 is as defined for formula I is carried out analogously to known procedures, for example as described in WO 98/42698 and references given therein, and comprises first oxidising a compound of formula Ill R-C W
R
2 (Il)
N
to yield a compound of formula V RFl W 0chlorinating or brominating that compound, for example with phosphorus oxychloride, phosphorus oxybromide, sulfuryl chloride, thionyl chloride or phosphorus pentachloride in phosphorus oxychloride, and then oxidising it again to form a compound of formula VIII WO 99/52893 PCT/EP99/02313 -16- Ri R N W (VIII),
N
Hal O0 the radicals R 1
R
2 and W in the compounds of formulae III, V and VIII being as defined and Hal in the compound of formula VIII being chlorine or bromine, then converting that compound in the presence of a solvent, e.g. water, an alcohol or a mixture thereof, or an amide, using a suitable sulfur reagent, e.g. hydrogen sulfide, thiourea, sodium hydrogen sulfide (NaSH) or phosphorus pentasulfide (P 2
S
5 into a compound of formula Im
R,
R
2 'W (Im),
N
S OH and reacting that compound in the presence of a solvent and a base with a compound of formula XI R42-L
(XI),
wherein R 42 is C1-C 6 alkyl, C 3
-C
6 alkenyl, C 3
-C
6 alkynyl, C1-C 6 haloalkyl, C 3
-C
6 haloalkenyl, Bi-C 1
-C
6 alkyl, C 1
-C
6 alkylcarbonyl, C 3
-C
8 trialkylsilyl, hydroxy-C 1 -Csalkyl or B 1 -C-Cshydroxyalkyl; B 1 is as defined; and L is a leaving group, e.g. halogen, for example chlorine, bromine or iodine, CHaSO20-, CH S s,0- or C 1 -Calkylcarbonyloxy.
The process according to the invention for the preparation of compounds of formula I
R
1 R /2 w (I)
N
Xl R3 wherein R 1
R
2
R
3 and W are as defined for formula I and X 1 is S is carried out analogously to known procedures, for example as described in WO 98/42698 and references given therein, and comprises treating a compound of formula I WO 99/52893 PCT/EP99/02313 -17- R1 R, w (1)
N
X, R 3 wherein R 2
R
3 and W are as defined and X, is O in an inert solvent with a sulfur reagent, for example phosphorus pentasulfide or Lawesson reagent.
For the preparation of the pyridine intermediates of formula III, a large number of known standard procedures of heterocyclic chemistry are available, the choice of a suitable preparation procedure being governed by the properties (reactivities) of the substituents in the respective intermediates.
The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in EP-A-0 438 209 or DE-OS 19 604 229, and, for the purpose of preparing compounds of formula III R1
R
2 W (Il)
-N
X3 Rio wherein Ri and R 2 are as defined for formula I, W is a group W, -N R 9 (Wi) and
N
X2
R
8 Re, R 9 Rio, X 2 and X 3 are as defined for formula I (corresponding to the compound of formula Illa in Reaction Scheme comprises, for example, converting a compound of formula XII (X
(XII),
WO 99/52893 PCT/EP99/02313 -18wherein R 1 and R 2 are as defined and Hal is fluorine, chlorine or bromine, in the presence of an inert solvent and ammonia, if appropriate in an autoclave at temperatures of from -10 to 180°C, into a compound of formula XIII
R,
R2 (XIII),
R
2
/NH
2
-N
converting that compound in the presence of a base and a solvent a) with a chloroformic acid ester of formula XIV
X
2
C,-C
4 alkylO----cl
(XIV),
wherein X 2 is as defined for formula I, into a compound of formula XV F x, I 2 or R NH-C-OC,-C 4 alkyl
N
b) with oxalyl chloride, phosgene or thiophosgene into a compound of formula XVI Ri
(XVI),
R
2
/N=C=X
2
N
then cyclising the compound of formula XV or XVI in the presence of from 0.1 to 1.5 equivalents of a base in an inert solvent with an enamine derivative of formula XVII R9
X,
C II Rio wherein R 9 and Ro are as defined for formula I and X 3 is oxygen, to yield a compound of formula XVIII WO 99/52893 PCT/EP99/02313 -19-
R
1
X
3
R
1 0 R N R 9 (XVIII), N r-N
X
2
H
wherein R 1
R
2
R
9 Rio, X 2 and X 3 are as defined, and reacting that compound further in the presence of an inert solvent and a base c) with a compound of formula XIX
R
8 -L
(XIX),
wherein R 8 is C 1
-C
3 alkyl or C 1
-C
3 haloalkyl and L is a leaving group, or d) with a hydroxylamine derivative of formula XX
NH
2 (XX), wherein L 1 is a leaving group.
The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in DE-A-4 423 934 and JP-A-58 213776, and, for the preparation of compounds of formula III R1
R
2 W
N
X
4 R 1 3 wherein R, and R 2 are as defined for formula I, W is a group W 2 -N R 12
(W
2
NN
Ri1 and R 1
R
12
R
13 and X 4 are as defined for formula I (corresponding to the compound of formula Illb in Reaction Scheme comprises, for example, either a) converting a compound of formula XII R1
S(XII),
R
2 Hal
-N
wherein R, and R 2 are as defined and Hal is fluorine, chlorine or bromine, with hydrazine, preferably in a protic solvent, into a compound of formula XXI WO 99/52893 PCT/EP99/02313 R1 f= ~(XXI), R2-\ /NH-NH 2
N
and reacting that compound further with a compound of formula XXII or XXIla O
O
R11 I I C C\ (XXII) or N ,C (XXIlla), II R12 R 2 0 1Hal Hal 12 wherein R, 1 and R 12 are as defined for formula I, and Hal in the compound of formula XXIIa is chlorine or bromine, or b) first diazotising a compound of formula XIII R1 RH,
(XIII),
R-
/NH
2
-N
wherein R, and R 2 are as defined, and then reacting further with a compound of formula XXIII
COOH
.CH R
C
R C R12 (XXlll), 11 1 0 0 wherein R 1 1 and R 12 are as defined, to yield a compound of formula XXIV R1 H R N R12
(XXIV),
N
N=C
R 11 which is optionally cyclised in the presence of a base, e.g. 4-dimethylaminopyridine, and a compound of formula XXV
X
4 P(phenyl) 3
(XXV)
CII II (XC),
C,-C
4 alkyl-O-C-C-R 13 wherein R 1 3 is as defined and X 4 is oxygen.
WO 99/52893 PCT/E P99/0231 3 -21 The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in EP-A-0 272 594, EP-A-0 493 323, DE-A-3 643 748, WO 95/23509, US-A-5 665 681 and US-A-5 661 109, and, for the preparation of compounds of formula III
R,
R
2 -W (Ill)
-N
X
9 wherein R, and R 2 are as defined for formula I, W is a group W 7 -N 24
(W
7 and
R
24
R
25
R
26
X
9 and Xio are as defined for formula I (corresponding to the compound of formula IlIg in Reaction Scheme comprises, for example, reacting either a) a compound of formula XVa S ^II (xva)
R
2
NH-C-OC-C
4 alkyl
-N
in the presence of a solvent and a base, or b) a compound of formula XVIa
R,
(XVIa),
R
2
N=C=X
10
N
if appropriate in a suitable solvent, the radicals R 1
R
2 and X 1 o in the compounds of formulae XVa and XVIa being as defined, with a compound of formula XXVI R X9 I 25 II
R
26
NH-C-C-OC,-C
4 alkyl (XXVI),
R
24 wherein R 24
R
25
R
26 and X 9 are as defined, to yield a compound of formula XXVII WO 99/52893 PCT/EP99/02313 -22-
R
1 R' X10 R X9 II 25 II (XXVII),
R
2 r NH-C-N--C-C-OC-C 4 alkyl I I N R R24
R
26
R
24 cyclising that compound in the presence of a suitable solvent and a base and then optionally c) when R 2 6 is hydrogen, reacting with a compound of formula XXVIII
R
26 -L
(XXVIII),
wherein R 2 6 is C1-C 3 alkyl and L is a leaving group.
The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in EP-A-0 210 137, DE-A-2 526 358, EP-A-0 075 267 and EP-A-0 370 955, and, for the preparation of compounds of formula III (R1) RC W
N
X
11 7 wherein R 1 and R 2 are as defined for formula I, W is a group W 8 -N N 2(W 8 and
X
1 2
R
27
R
28
X
11 and X 12 are as defined for formula I (corresponding to the compound of formula Illh in Reaction Scheme comprises, for example, reacting a) a compound of formula XVb 1 2 (XVb)
R
2
//NH-C--OC-C
4 alkyl
N
in the presence of a solvent and a base, or b) a compound of formula XVIb WO 99/52893 PCT/EP99/02313 -23-
R,
(XVIb),
R
2 N /N=C=X 12
N
the radicals R 1
R
2 and X 1 2 in the compounds of formulae XVb and XVIb being as defined, if appropriate in a suitable solvent, with a compound of formula XXIX
X,,
II
I
R
28 NH-N-C-OC,-C~alkyl
(XXIX),
R27 wherein R 27
R
28 and X 1 1 are as defined, to yield a compound of formula XXX R1 X12 X11 NH- N C-OCl.C4alky
I
R
28 R 27 cyclising that compound in the presence of a suitable solvent and a base, and then optionally c) when R 27 and/or R 28 are hydrogen, reacting further with a compound of formula XXXIa or XXXIb
R
27 -L (XXXIa) or R2a-L (XXXIb), wherein R 27 and R 28 are each independently of the other C 1
-C
3 alkyl and L is a leaving group, or with a Michael acceptor.
The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in WO 97/07114, 306 694, DE-A-3 832 348, EP-A-0 257 479 and EP-A-0 500 209, and, for the preparation of compounds of formula III WO 99/52893 PCT/EP99/02313 24
R
1 4 wherein R, and R 2 are as defined for formula 1, W is a group W 3
R
15
(W
3 and
R
1 4
R
15 and R 1 6 are as defined for formula I (corresponding to the compound of formula I11c in Reaction Scheme comprises, for example, condensing a compound of formula XXI
R
2 HX NHNH 2
(XXI),
N
wherein R, and R 2 are as defined, a) with a compound of formula XXXII o 0 II C I R IX
I
R
1 4 C H 16XI)
R
1 wherein R 14 is hydrogen, 0 1
-C
3 alkyl or 0 1
-C
3 haloalkyl; R 1 5 is hydrogen, C 1 -C~alkyl,
C
1
-C
4 haloalkyl, 0 2
-C
4 alkenyl, 0 3
-C
5 haloalkenyl or 03- or C 4 -alkynyl and R 16 is hydrogen,
C
1
-C
4 alkyl or 0 1
-C
4 haloalkyl, if appropriate in the presence of an acidic, basic or bifunctional catalyst, e.g. p-toluenesulfonic acid, or b) with a compound of formula XXXIla o 0 II1 I ~C C NR XXl)
L
2 CH 16(XXa) R 1 wherein R 1 5 and R 16 are as defined and L 2 is a suitable leaving group, to form a compound of formula XXXIII
R
2 I N N R1 (XXXIII), WO 99/52893 PCT/EP99/02313 and functionalising the pyrazolone group further in accordance with the definition of R 14 analogously to known procedures, for example using a halogenating agent, e.g.
phosphorus oxychloride, to form the corresponding halogen derivative of formula Illc R1 N R 16 R N N NX (11c), R 14 R wherein R 1
R
2
R
1 i and R 16 are as defined and R 14 is halogen (Reaction Scheme 6).
The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in EP-A-0 370 332, EP-A-0 370 955 or DE-A-3 917 469, and, for the preparation of compounds of formula III
RR
R2 W
-N-N
R17
R
wherein R1 and R2 are as defined for formula I, W is a group W4 N R9 NjO 19
N
(W
4 and R17, R 1 e and R 19 are as defined for formula I (corresponding to the compound of formula Illd in Reaction Scheme comprises, for example, condensing a compound of formula XXI R- C -NHNH,
(XXI),
-N
wherein R, and R 2 are as defined, a) with a compound of formula XXXIIb WO 99/52893 PCT/EP99/02313 -26- 0 0
II
RC' 17 (XXXllb), R19 wherein R 18 and R 19 are as defined and R 1 7 is hydrogen, C 1
-C
4 alkyl or C 1
-C
4 haloalkyl, if appropriate in the presence of a catalyst, or b) with a compound of formula XXXlIc O 0 I
R
18 (XXXIIc), R18 R19 wherein RIe and R 1 9 are as defined and L 2 is a suitable leaving group, to form a compound of formula XXXIIIla R 1
R
N
R RN (XXXIIla) NR19 and treating that compound with a halogenating agent, e.g. a phosphorus oxyhalide or thionyl halide, to yield a compound of formula IlId R, R N N 18
R
2 NR9 (lld), R17 wherein R 1
R
2 Rie and R 1 9 are as defined and R 17 is halogen, and optionally reacting that compound with a cyanide of formula XXXIV M(CN)s (XXXIV), wherein M is an ammonium cation, an alkali metal ion or a metal ion from sub-group I or II of the Periodic Table of the Elements and s is the number 1 or 2, if appropriate in the presence of an alkali metal iodide (R 17 cyano) (Reaction Scheme 7).
WO 99/52893 PCT/E P99/02313 -27- The process according to the invention for the preparation of compounds of formula II! is carried out analogously to known procedures, for example as described in DE-A-3 917 469, WO 92/00976, US-A-5 069 711 and EP-A-0 260 228, and, for the preparation of compounds of formula III Ri 2R W
-N
X6 wherein R, and R 2 are as defined for formula I, W is a group W 5 -N (W 5 or X
XX
R
2 2 W6 N R 23
(W
6 and R 2 0
R
21
R
22
R
2 3 and Xs to Xa are as defined for
X
7 formula I (corresponding to the compounds of formulae Ille and Illf, respectively, in Reaction Scheme comprises, for example, reacting a) a compound of formula XXXV
O
R21 R 1 0 (XXXV) or
O
b) a compound of formula XXXVa R22
O
R
23 I 0 (XXXVa), 0 the radicals R 20 to R 23 in the compounds of formulae XXXV and XXXVa being as defined, with a compound of formula XIII WO 99/52893 PCT/EP99/02313 -28-
(XIII),
wherein R 1 and R 2 are as defined, in an inert solvent in the presence of a C 1
-C
4 alkylcarboxylic acid at temperatures of from 200 to 2000C, and optionally converting the resulting compound of formula Ille or Illf
R
1
X
8 (Ille) or R 2
N
N R23 (llif), wherein R 1
R
2 and R 20 to R 2 3 are as defined and Xs to X 8 are oxygen, with the aid of a suitable sulfur reagent, into the corresponding thiono compound of formula Ille or IlIf wherein Xs and/or X 6 and X 7 and/or X 8 are sulfur respectively (Reaction Scheme 8).
The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in WO 95/00521, EP-A-0 611 708 and WO 94/25467, and, for the preparation of compounds of formula III
R,)
(III)
wherein R, and R 2 are as defined for formula I, W is a group W 9
X
1 3
N
X
-N
R
(W
9 and
R
29 Rao, X 1 3 and X1 4 are as defined for formula I (corresponding to the compound of formula Illi in Reaction Scheme comprises, for example, reacting a) a compound of formula XVc WO 99/52893 PCT/EP99/02313 -29- R X14 II (XVc) or R2 H NH-C-OC,-C4 alkyl c o r
-N
b) a compound of formula XVIc R1
R
2
N=C=X
1 4 (XVIc),
N
the radicals R 1
R
2 and X1 4 in the compounds of formula XVc and XVIc being as defined, if appropriate in the presence of a solvent and a base, with a compound of formula XXXVI
R
30
-NH-NH-R
29
(XXXVI),
wherein R 29 and R 30 are as defined for formula I, to yield a compound of formula XXXVII R 1 X1
R
2 NH-C-N-NH-R2 (XXXVII), N
R
and then reacting that compound, if appropriate in a solvent and in the presence of a base, with a (thio)carbonylating reagent of formula XXXVIII L3.
/C=X
1 3
(XXXVIII),
L
3 wherein X 1 3 is as defined and L 3 is a leaving group (Reaction Scheme 9).
The process according to the invention for the preparation of compounds of formula III is carried out analogously to known procedures, for example as described in US-A-5 980 480, DE-A-3 917 469, US-A-4 818 275, US-A-5 041 155 and EP-A-0 610 733, and, for the preparation of compounds of formula III R1 =(IlI)
N
WO 99/52893 PCT/E P99/02313 Xis R31 wherein R, and R 2 are as defined for formula I, W is a group W 1 0 N (WX
W
R32 and R 31
R
32 and X 1 s are as defined for formula I (corresponding to the compound of formula IIIk in Reaction Scheme 10), comprises, for example, a) reacting a compound of formula XXI R,
NHNH
2
(XXI),
N
if appropriate in the presence of a catalyst, with a compound of formula XXXIX
R,
32 C=o (XXXIX)
HOOC
to form a compound of formula XXXX R 1
RIR
232
NHN=C(XXXX),
R
2
~/NHN=C
N COOH the radicals R 1
R
2 and R 32 in the compounds of formulae XXI, XXXIX and XXXX being as defined, and cyclising the compound of formula XXXX by further reaction with an azide of formula XXXXI
O
11
(XXXXI)
P(OC,-C
4 alkyl) 2 (Xis O, R 3 1 or b) cyclising a compound of formula XXI R1NHNH
R
2
NHNH
2
(XX)
N
with a compound of formula XXXXIII WO 99/52893 PCT/EP99/02313 -31
OC,-C
4 alkyl N-C OOC alky (XXXXIII), R32 N-COOC,4alky the radicals R 1
R
2 and R 32 in the compounds of formulae XXI and XXXXIII being as defined,
(X
1 5 O, R 3 1 or c) reacting a compound of formula XXI R1(XXI)
R
2 C -NHNH 2
-N
first with a compound of formula XXXXIV
R
32 -CHO
(XXXXIV)
to form a compound of formula XXXXa
R,
R
2 NH-N=CH-R3 (XXXXa),
N
and then with an alkali metal cyanate to form a compound of formula XXXXV
R,
R- -N=CH-R 2
(XXXXV)
NH
2 0 and finally cyclising that compound in the presence of an oxidising agent, to yield a compound of formula Illk R 1 X\ N R 3, R N (Illk), N N R32 wherein R 1
R
2 and R 32 are as defined, X 1 s is oxygen and R 31 is hydrogen, and optionally treating that compound with a sulfur reagent (Xs 1 S) and, in the presence of a base, with an alkylating reagent of formula XXXXII
(XXXXII),
WO 99/52893 PCT/EP99/02313 32 wherein R 31 is C 1
-C
4 alkyl, C 1 -C~haloalky, C3- or C 4 -alkenyl, 03- or C 4 -haloalkenyl or C3- or
C
4 -alkynyl and L is a leaving group.
The preparation of the compounds of formula Ilila
RX
3
R
1 0 RC N R 9 (Ilila) 2
N
X
2 R 8 wherein R 1
R
2
R
8
R
9
R
10
X
2 and X 3 are as defined for formula I is illustrated in Reaction Scheme 2 below.
WO 99/52893 PCT/EP99/02313 -33- Reaction Scheme 2:
R,
H NH 3 (autoclave)
R
2 Hal solvent, -10-180 2 solvent, -10-180°C
N
Ri
R
2 NH 2
N
a) CIC(X 2
)O-C,-C
4 alkyl or
XIV
b) oxalyl chloride or C(X 2
)CI,,
base, solvent R X2 SNH O-C,-Calkyl
N
XV
or Ri
R
2
NC=X
2
N
R
9
X
3 S U ,C,-C4alkyl
NH
2 0 Rio
XVII
base, solvent
R
1
X
3 Rio R- N R 9 N N\
X
2
H
XVIII
c) R-L or
XIX
d) NH,-L,
XX
base, solvent
R
1
X
3
R
1 0
R
2 N R 9
R
N -N X, R, thionation reagent, e.g.
Lawesson reagent solvent
R
1
X
3
R
10 R N
R
9 N
R
X2 R, Ilia (X 3
=S)
Ilia (X 3
=O)
For the preparation of the compounds of formula Ilia according to the invention, a large number of known standard procedures are available, for example as described in EP-A-0 438 209 and DE-OS-19 604 229 (R 9 =cyano). Reaction Scheme 2 shows a selection of suitable preparation procedures, the choice of the reaction routes and the reagents being governed by the reactivities of the substituents in the intermediates.
Starting, for example, from a compound of formula XII, it is possible by reaction with ammonia in an inert solvent, if appropriate in an autoclave at temperatures of from -10 to 180C, to obtain an aminopyridine of formula XIII. The latter compound may be converted in the presence of a base and a solvent either WO 99/52893 PCT/EP99/02313 -34a) with a chloroformic acid ester of formula XIV (X 2 O or S) into a pyridyl carbamate of formula XV, or b) with oxalyl chloride, phosgene (X 2 or thiophosgene (X 2 into an iso(thio)cyanate of formula XVI. Such reactions are described, for example, in Angew. 1971, 407.
The carbamate and the iso(thio)cyanate of formulae XV and XVI may be cyclised in the presence of an enamine derivative of formula XVII in an inert solvent to form a uracil derivative of formula XVIII, the reaction of the iso(thio)cyanate of formula XVI advantageously being carried out in the presence of from 0.1 to 1.5 equivalents of a base, e.g.
sodium hydride, potassium tert-butanolate or an alkaline earth metal oxide or hydroxide, e.g. barium hydroxide.
The desired compounds of formula Ilia may be prepared in accordance with standard procedures from the uracils of formula XVIII in the presence of an inert solvent and at least one equivalent of a base, for example an alkali metal carbonate, such as potassium carbonate, c) with an alkylating agent of formula XIX to form the N-alkyl derivative of formula Ilia (Re =alkyl), or d) analogously to WO 97/05116 with a hydroxylamine derivative of formula XX, wherein L 1
CH,
NO
2 H 3 is a leaving group, e.g. HOS(O) 2 NO2 or H,C
OS(O)-
CH
3 for example 2,4-dinitrophenyl-hydroxylamine or hydroxylamine-O-sulfonic acid, to form the N-amino derivative of formula Ilia (R 8 =amino). The desired thiono derivatives of formula Ilia (X 2 Xa may be obtained by thionation, for example with phosphorus pentasulfide or Lawesson reagent.
The preparation of the compounds of formula IlIb R X 4
R
1 3 R2- N N R12 (Illb), N N=< WO 99/52893 PCT/EP99/02313 35 wherein R 1
R
2 R, 1
R
1 2
R
13 and X 4 are as defined for formula 1, is illustrated in Reaction Scheme 3 below.
Reaction Scheme 3:
R
1 R ~~NH 2 NH 2
RNN
R
2 Hal solvent R NHH N
N
XII
XXI
O-Z R12 0C R1 or Br-C i Br XXII XXia X4
R
13 c-C R I X 4 R 13 C a ky o/ h 3R i 12XXV- N N- N N=C
XXIV
1) diazotisation (preferably with exclusion of water) 2)OZ.C 2Japp-Klingemann I reaction
CH
COOH R 1 1
XXIII
R
2 7 NH 2
N
XIII
The compounds of formula Illb may be prepared in accordance with known methods, for example in accordance with Reaction Scheme 3 (variant by reacting a 2-halopyridine WO 99/52893 PCT/EP99/02313 -36derivative of formula XII with hydrazine, preferably in a protic solvent, e.g. an alcohol, analogously to GB-A-2 230 261 to form a 2-hydrazino derivative of formula XXI.
The latter is reacted with a diketone of formula XXII analogously to DE-OS-19 754 348 or with a dihaloketone of formula XXIIa analogously to WO 97/07104 to form a hydrazone derivative of formula XXIV.
The subsequent cyclisation to form the desired compound of formula Illb is carried out in the presence of a phosphorane derivative of formula XXV if appropriate in the presence of a base, for example 4-dimethylaminopyridine. Then, for the case where X 4 in a compound of formula Illb O, thionation (X 4 S) may be carried out in a manner analogous to that described under Reaction Scheme 2.
According to Reaction Scheme 3, the hydrazone derivative of formula XXIV may also be obtained from the 2-aminopyridine derivative of formula XIII via diazotisation, preferably with exclusion of water, and subsequent coupling to the ketonic acid of formula XXIII (Japp- Klingemann reaction analogously to DE-OS-19 754 348) (variant b) in Reaction Scheme 3).
The preparation of the compounds of formula IlIg
R
1 9 R2- N (N Rg)2 N t 26
X
10 wherein R 1
R
2
R
24
R
25
R
26
X
9 and X 1 o are as defined for formula I, is illustrated in Reaction Scheme 4 below.
WO 99/52893 WO 9952893PCT/EP99/023 13 -37 Reaction Scheme 4:
O-C
1 -C 4 alkyl XVa
X
9 R 26 N C 0-,cl 4 alk
R
2 4
R
25
XXVI
base, solvent or b) R 2 N=C=X 10
N
XVIa 2 R 9 N N4
NN\
X
1 0 R 26 Ilug X 10 0) RiC 1
-C
4 alky\ R 2
NN
R
26
XXVII
base, solvent alkylation, e.g. R 26
-L
4 base, solvent XVl RI X 9
R
2 /N \IfR 2 4
NN\
X0 R26 4thionation e.g.
Lawesson reagent RI X 9
R
2 N
N\
X
10 R 26 Ilug X 10
=S)
The compounds of formula IlIg may be prepared analogously to known methods, for example as described in EP-A-0 272 594, EP-A-O 493 323, DE-A-3 643 748, WO 95/23509, 665 681 or US-A-5 661 109.
For example, in accordance with Reaction Scheme 4 either a) a carbamate derivative of formula XVa may be cyclised in the presence of a solvent and a base, or WO 99/52893 PCT/EP99/02313 -38b) an iso(thio)cyanate of formula XVIa may be cyclised, if appropriate in a suitable solvent, with an amino acid derivative of formula XXVI via a compound of formula XXVII in the presence of a base and a suitable solvent to form a compound of formula 111g.
For the case where in a compound of formula IlIg R 26 is hydrogen and Xg and/or X 1 0 are oxygen, then optionally alkylation may be carried out at the free N atom of the hydantoin ring using an alkylating reagent of formula XXVIII and the ring carbonyl group may be thionated (X 9 and/or X 1 0
S).
The preparation of compounds of formula IlIh
R
1
X
11 27 R (111h), N R R 28
X
12 wherein R 1
R
2
R
27
R
28
X
11 and X 12 are as defined for formula I, is illustrated in Reaction Scheme 5 below.
WO 99/52893PC/9/031 PCT/EP99/02313 39 Reaction Scheme a) R 2
O-C
1
-C
4 a b 2 N CX
N
XVb Ikyl N X11 R~8N\,,C1-C 4 alkyl
R-
27
XXIX
base, solvent
R
1 R 27 /C,-Calk
N
1 N Xl
X
1 2 N 28 base, solvent R, X11 2
R
1
X
11
/R
27
N
N
I
l1lh X 1 2 0) jthionation, e.g.
Lawesson reag alkylation, e.g. R 27 R 28 or XXXIa XXXIb Michael acceptor, base, solvent R I X 1 1
/R
27 N
X
12 R 28 lllh X, 2
=S)
The compounds of formula Illh may be prepared analogously to known procedures, for example as described in EP-A-0 210 137, DE-OS-2 526 358, EP-A-0 075 267 or EP-A-0 370 955.
For example, in accordance with Reaction Scheme 5 either WO 99/52893 PCT/EP99/02313 a) a carbamate derivative of formula XVb may be cyclised in the presence of a solvent and a base, or b) an iso(thio)cyanate of formula XVIb may be cyclised, if appropriate in a suitable solvent, with a carbazate of formula XXIX via a compound of formula XXX in the presence of a base and a suitable solvent to form a compound of formula Illh.
For the case where in a compound of formula Illh R 27 and/or R 28 are hydrogen and X, and/or X 1 2 are oxygen, then alkylation may be carried out at the free N atoms using an alkylating agent of formula XXXIa or XXXIb and the ring carbonyl groups may be thionated (XI, and/or X 12 S) using a thionating reagent.
For the preparation of compounds of formula Illh in Reaction Scheme 5 wherein R 27 and R 28 together form an alkylene bridge that is interrupted e.g. by for example a compound of formula Illh wherein R 27 and R 28 are hydrogen may be reacted with a corresponding Michael acceptor, for example CH 2 =CH-S(0) 2
CH
3 or CH 2 =CH-S(0) 2
-CH=CH
2 and the resulting Michael addition products may be functionalised further.
The preparation of the compounds of formula Illc
N
RR1 R14 wherein R 1
R
2 and R 14 to R 16 are as defined for formula I, is illustrated in Reaction Scheme 6 below.
WO 99/52893 PCT/EP99/02313 -41 Reaction Scheme 6: 0 O II II C a) R CH iR S14 16
R
15 R16 R NHNH 2 R N R 1 6 N
N
N-
XXI R 145 IIII IIIc b) L-'CHCR, XXXlla R1 R1 RN R 1 6 halogenation reagent, e.g. -R N R 16
R
2 POC2 O R N O R15 R14 R14 XXXIII IlIc (R 1 4 halogen) In accordance with Reaction Scheme 6, the pyrazole compounds of formula Illc may be prepared, for example, either from the hydrazinopyridine derivatives of formula XXI by means of condensation with a 1,3-dicarbonyl derivative of formula XXXII (variant or by means of condensation with a P-carbonylcarboxylic acid derivative of formula XXXIla wherein L 2 is a leaving group, for example Ci-C 4 alkoxy, hydroxy or halogen, e.g. chlorine or bromine, (variant and subsequent treatment of the resulting pyridylpyrazolone derivative of formula XXXIII with a halogenating agent, for example phosphorus oxychloride
(R
1 4 =halogen). The two reaction steps a) and b) in Reaction Scheme 6 are effected, if appropriate, in the presence of an acidic, basic or bifunctional catalyst, e.g. ptoluenesulfonic acid.
The compounds of formula Illc obtained in this way may be functionalised further in accordance with the definitions of the substituents R 14 to R 1 6 by means of standard procedures.
The compounds of formula IlIc in Reaction Scheme 6 wherein R 1 5 is hydrogen may be functionalised further in accordance with the definition of R 15 for example with an electrophilic reagent, e.g. a halogenating agent, such as elemental halogen or sulfuryl WO 99/52893 PCT/EP99/02313 -42halide, to form the corresponding compounds of formula Illc wherein R 1 5 is halogen, or with a nitrating agent, such as nitric acid, if appropriate in admixture with a further strong acid, such as sulfuric acid, to form the corresponding compounds of formula IlIc wherein R 1 i is nitro.
The corresponding pyridono derivatives of formula Ic
R,
R N R 16 R N R l c), X,
R
1 R wherein R 1 to R 3
R
14 to R 1 6 and X 1 are as defined for formula I, may be obtained, as described above, from compounds of formula IlIc by means of oxidation of the pyridyl moiety.
In a further variant, the pyridono derivatives of formula Ic may also be obtained directly from the corresponding pyridonylhydrazines of formula XXla Ri R2 NHNH 2 (XXIa), X,
R
3 wherein R 1 to R 3 and X, are as defined, analogously to the variants shown in Reaction Scheme 6.
The required pyridonylhydrazine of formula XXIa may readily be obtained from the corresponding pyridonyl halide of formula Xlla R1 R2 Hal (Xlla),
N
X
1 R 3 wherein R 1
R
2 and R 3 are as defined and Hal is fluorine, chlorine or bromine, with hydrazine, preferably in a protic solvent.
In certain cases, the compounds of formula Ic may also be obtained in manner analogous to that described in J. Het. Chem. 15, 1221 (1978) and in Reaction Scheme 11, by substitution of a pyridonyl derivative of formula Xlla that is provided with a leaving group L 4 WO 99/52893 PCT/EP99/02313 -43e.g. a halide, a C1-C 4 alkyl- or phenyl-sulfonyl group or an unsubstituted or substituted C 1
C
4 alkyl- or phenyl-sulfonyloxy group, (variant c) in Reaction Scheme 11), or by substitution of a pyridine derivative of formula XII that is provided with a leaving group 14, e.g. a halide, a C 1
-C
4 alkyl- or phenyl-sulfonyl group or an unsubstituted or substituted C 1
-C
4 alkyl- or phenyl-sulfonyloxy group, (variant d) in Reaction Scheme 11), with a pyrazole of formula
W
03 or an alkali metal salt thereof, and in the case of variant d) by subsequent functionalisation (oxidation) of the pyridyl moiety of the compound of formula IlIc. The substitution reactions according to variants c) and d) may optionally be carried out in the presence of a suitable solvent and a base.
Reaction Scheme 11: N
R
16
HN
1 R 15 W0 3 solvent, base Ic t0] The preparation of the compounds of formula IIId (Ilid) wherein R 1
R
2 and R 1 7 to R 19 are as defined for formula I is illustrated in Reaction Scheme 7 below.
WO 99/52893 PCT/EP99/02313 -44- Reaction Scheme 7: 0 0 a) R R1 R R, R2 NHNH 2 XXXIIb R N 18 N
N
R XXI R17 R 1 O O IIId b)
R,
N i POCI 3 or SOCI, 2 'N XXXIlla R,7 R,, IIId (R 1 7 halogen)
M(CN)
s
XXXIV
IIId (R 1 7
CN)
In accordance with Reaction Scheme 7, the tetrahydroindazole compounds of formula Illd may be obtained according to known procedures from the hydrazinopyridine derivatives of formula XXI, for example either by condensation with a cyclohexanone derivative of formula XXXIIb that is acylated in the 2-position, wherein R 1 7 is as defined for formula I with the exception of R 1 7 as halogen or cyano, (variant or by condensation with a cyclohexanone derivative of formula XXXIIc wherein L 2 is a leaving group, for example Ci-C 4 alkoxy, hydroxy or halogen, e.g. chlorine or bromine, and subsequent halogenation (variant in a manner analogous to that described under Reaction Scheme 6.
The halogen derivatives of formula IlId wherein R 1 7 is halogen may be converted into the corresponding cyano-substituted derivatives of formula IlId (R 17 =CN) according to known methods with an alkali metal cyanide, ammonium cyanide or a metal cyanide, the metal being selected from sub-groups I and II of the Periodic Table of the Elements, if appropriate with the addition of an alkali metal iodide.
WO 99/52893 PCT/EP99/02313 The preparation of the compounds of formulae Ille and Illf
R
1
X
6 R 1
X
8 R2- N I (lle) and R 2 (lf),
R
20
XN
wherein R 1
R
2
R
20 to R 2 3 and Xs to X 8 are as defined for formula I, is illustrated in Reaction Scheme 8 below.
Reaction Scheme 8:
R,
21 O 2 N 2 R 1
X
6 a) XIII R 21 solvent, propionic acid, 2
R
20 20-200*C N SXs R 20
XXXV
Ille
X
6 =0) R1 R2- C NH 2 R22 O N R 1
X
8 b) XIII O solvent, propionic acid, N 20-200'C
N
R23 X R23 XXXVa Illf (X 7
X
8 0) In accordance with Reaction Scheme 8, the pyrrolinedione derivatives of formula Ille and the tetrahydroisoindolinedione derivatives of formula IlIf may be obtained analogously to known procedures, for example by reaction of an anhydride of formula XXXV (variant or XXXVa (variant with an aminopyridine of formula XIII in an inert solvent, for example an ether, e.g. dioxane, or a lower alkylcarboxylic acid, e.g. propionic acid, at temperatures of from 20 to 200 0
C.
The compounds of formulae Ille and Illf (Xs to Xe 0) obtained in accordance with Reaction Scheme 8 may optionally be thionated with a suitable sulfur reagent (Xs to Xe S).
WO 99/52893 PCT/E P99/02313 -46- The corresponding pyridono derivatives of formulae le and If R, X 6 R 1 X, 22 R2 N (le) and R -N N
N
X RX 5 20 23 SX
R
3
X
7 may be obtained from the compounds of formulae Ille and Illf as described above, by means of oxidation of the pyridyl moiety.
In a further variant, the pyridono derivatives of formulae le and If may also be obtained directly from the corresponding aminopyridone derivatives of formula Xllla R1 R NH 2 (Xllla),
N
X,
R
3 wherein R 1
R
2
R
3 and X, are as defined for formula I, analogously to the method as described in Reaction Scheme 8.
The preparation of the compounds of formula Illi
R
2 (Illi) N N-N RR3° R/ Ra R29 wherein R 1
R
2
R
29
R
3 0 X13 and X 14 are as defined for formula I is illustrated in Reaction Scheme 9 below.
WO 99/52893 PCT/EP99/02313 -47- Reaction Scheme 9:
R
1 4 a) R 2
OC,-C
4 alkyI N X 4 XVc RNH-NHR 29 1 XXXVI A
R
2 /p~N NNH solvent, R base
XXXVII
b) R 2
N=C=X
1 4 N solvent, L3 XVIc base X3 L3
XXXVIII
R
1 R2-- N N N29 Illi In accordance with Reaction Scheme 9, the compounds of formula Illi may be prepared according to known procedures, for example by first reacting a carbamate of formula XVc (variant or an isothiocyanate of formula XVIc (variant with a hydrazine derivative of formula XXXVI to form a semicarbazide derivative of formula XXXVII and then reacting the latter in the presence of a carbonylating or thiocarbonylating reagent of formula XXXVIII.
Both reaction steps are advantageously carried out in a suitable solvent and in the presence of a base. As (thio)carbonylating reagent of formula XXXVIII there come into consideration e.g. phosgene, diphosgene, thiophosgene and carbonyldiimidazole. La in formula XXXVIII is therefore a leaving group, for example halogen, e.g. chlorine or bromine, trichloromethoxy or .N The corresponding pyridono derivatives of formula li WO 99/52893 PCT/E P99/02313 -48-
RR
R N (li), N N-N
X
1 R3 R29 wherein R 1 to R 3
R
29
R
30
X
1
X
13 and X1 4 are as defined for formula I, may be obtained from the compounds of formula Illi in the manner described above, by means of oxidation of the pyridyl moiety.
In a further variant, the pyridono derivatives of formula ii may also be obtained directly from the corresponding pyridone carbamates of formula XVd
X
1 4 1II
R
2
NH-C--OC-C
4 alkyl (XVd)
N
X
R3 or from the iso(thio)cyanates of formula XVId R1 R -N=C=X 1 4 (XVId), X, R 3 the radicals R, to R 3 X, and X 14 in the compounds of formulae XVd and XVId being as defined for formula I, in a manner analogous to that described in Reaction Scheme 9.
The required starting compounds of formulae XVc and XVIc are known and are described, for example, in EP-A-0 468 924 and EP-A-0 304 920.
The preparation of the compounds of formula Illk R1 R N R32(Ik), R 2 N'r (111k), N Xl R 3 1 wherein R 1
R
2
R
31
R
32 and X 5 i are as defined for formula I, is illustrated in Reaction Scheme 10 below.
WO 99/52893 PCT/E P99/02313 -49- Reaction Scheme a) cUo H Ft. N-(OOC,-ca, N Rm XXx^ /a_ eg /G NHN=< N NY Moo.u.onor: a _N COOH N XXXX s IIIk (X 5
R
3 1
=H)
se b) OC,-c, cL4s s a gaB m 2 R 4 R
RN
x'N' N R m R-L bee N' R2-< -O -NHNH R2- C\ I -N COv "N N N N Ll XXI Xis R 3 1 R31 Ilk R3=H) IIIk
R
31 Ft,-Ltse ),,prepared analogously to known procedures, for example by using as starting material reacted with a keto acid of formula XXXX, advantageously in the presence of an acid 2)catalyst, e.g. a lower alkylcarboxylic acid, e.g. propionic acid, a mineral acid, e.g. sulfuric N-NL- /I -N=CHR, g. R /F N NY acryrcrcac r a sulfo N tNH 2 N r r
S
lllk (X 1
R,=H)
In accordance with Reaction Scheme 10, the triazolone derivatives of formula Illk may be prepared analogously to known procedures, for example by using as starting material a hydrazinopyridine derivative of formula XXI which, in accordance with variant is reacted with a keto acid of formula XXXIX, advantageously in the presence of an acid catalyst, e.g. a lower alkylcarboxylic acid, e.g. propionic acid, a mineral acid, e.g. sulfuric acid or hydrochloric acid, or a sulfonic acid, e.g. p-toluenesulfonic acid, to form a hydrazone derivative of formula XXXX The latter may then be cyclised with an azide of formula XXXXI to form a triazolone derivative of formula Illk wherein X 1 is oxygen and R 3 1 is hydrogen and then optionally derivatised further in accordance with standard procedures with an alkylating reagent of formula XXXXII or with a sulfur reagent.
In accordance with variant a hydrazinopyridine derivative of formula XXI may be cyclised with an imino ether of formula XXXXIII to form a triazolone derivative of formula Illk wherein
X
1 s is oxygen and R 31 is hydrogen and then optionally alkylated or thionated as described under variant a).
In accordance with variant in Reaction Scheme 10 a hydrazinopyridine derivative of formula XXI may be converted first with an aldehyde of formula XXXXIV, then in the presence of a lower alkylcarboxylic acid, e.g. acetic acid, with an alkali metal cyanate to form a compound of formula XXXXV, which may or may not be isolated, and finally cyclised WO 99/52893 PCT/EP99/02313 with an oxidising agent, e.g. an alkali metal hypochlorite (Javelle), to form a compound of formula Illk wherein X 1 i is oxygen and R 31 is hydrogen. The resulting compound of formula Illk may then optionally be alkylated or thionated as described under variant a).
The corresponding pyridono derivatives of formula Ik R1 R2N r 3 2 N N (Ik),
X
1 R 3 X 15 R31 wherein R, to R 3
R
3 1
R
32 X, and X 1 5 are as defined for formula I, may be obtained from the compounds of formula Illk as described above, by means of oxidation of the pyridyl moiety.
As a further variant, the pyridono derivatives of formula Ik may also be obtained directly from the corresponding pyridonylhydrazines of formula XXla R1 R-
NHNH
2 (XXIa),
N
X, R 3 wherein R, to Ra and X 1 are as defined, in a manner analogous to the variants shown in Reaction Scheme The compounds of formulae XII and XIII are known or may be prepared in accordance with known methods, for example as described in DE-A-3 917 469; WO 97/07114; WO 92/00976; JP-A-58-213 776; EP-A-0 012 117; EP-A-0 306 547; EP-A-0 030 215; EP-A-0 272 824; EP-A-0 500 209; US-A-4 996 323; US-A-5 017 705; WO 97/05112; J. Het. Chem.
11, 889 (1974); J. Het. Chem 21, 97 (1984); Tetrahedron 41, 4057 (1985); Heterocycles 22,117; Synth. 1988, 938; J. Med. Chem. 25, 96.
The 2-aminopyridines of formula XIII may also be prepared by degradation reactions according to Curtius, Hofmann or Lossen from corresponding pyridine derivatives with carboxylic acid, carboxylic acid chloride, carboxylic acid azide, carboxylic acid ester or carboxylic acid amide functions in the 2-position.
The compounds of formulae XII and Xlla in Reaction Scheme 11 wherein L. is a leaving group, e.g. a Ci-C 4 alkyl- or phenyl-sulfonyl group, are known or may be prepared in accordance with known methods, for example by oxidation of the corresponding thioethers WO 99/52893 PCT/E P99/02313 -51 with hydrogen peroxide or Javelle water or by means of the synthesis of the heterocycle.
Such syntheses are described, for example, in Synthesis 1989, 623 or in WO 98/11071.
The reagents of formulae XIV, XVa, XVb, XVIa, XVIb, XVII, XIX, XX, XXII, XXlla, XXIII, XXV, XXVI, XXVIII, XXIX, XXXIa, XXXIb, XXXII, XXXlla, XXXIIb, XXXIIc, XXXIV, XXXV, XXXVa, XXXVI, XXXVIII, XXXIX, XXXXI, XXXXII, XXXXIII and XXXXIV used in Reaction Schemes 2 to 10 are either known or may be prepared in analogy to known methods.
The intermediates of formula II RRi R 1
R
2 W RW
(II),
N
NH
OH
O
in which R 1
R
2 and W are as defined for formula I and which may be in the tautomeric keto-enol form, are novel. The invention therefore relates to those compounds also.
The reactions to form compounds of formula I are advantageously carried out in aprotic, inert organic solvents. Such solvents are hydrocarbons, such as benzene, toluene, xylene or cyclohexane, chlorinated hydrocarbons, such as dichloromethane, trichloromethane, tetrachloromethane or chlorobenzene, ethers, such as diethyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, tetrahydrofuran or dioxane, nitriles, such as acetonitrile or propionitrile, amides, such as N,N-dimethylformamide, N,N-diethylformamide or N-methylpyrrolidinone. The reaction temperatures are preferably from -20°C to +120C.
The reactions are generally slightly exothermic and may usually be carried out at room temperature. In order to shorten the reaction time or alternatively to initiate the reaction, the reaction mixture may be heated to its boiling point for a short time. The reaction times may likewise be shortened by the addition of a few drops of base as reaction catalyst. Suitable bases are especially tertiary amines, such as trimethylamine, triethylamine, quinuclidine, 1,4-diazabicyclo[2.2.2]octane, 1,5-diazabicyclo[4.3.0]non-5-ene or diazabicyclo[5.4.0]undec-7-ene, but it is also possible to use inorganic bases, such as hydrides, e.g. sodium or calcium hydride, hydroxides, such as sodium or potassium hydroxide, carbonates, such as sodium or potassium carbonate, or hydrogen carbonates, such as potassium or sodium hydrogen carbonate.
WO 99/52893 PCT/EP99/02313 -52- The compounds of formula I can be isolated in customary manner by concentration and/or evaporation of the solvent and can be purified by recrystallisation or trituration of the solid residue in solvents in which they are not readily soluble, such as ethers, aromatic hydrocarbons or chlorinated hydrocarbons, or by means of column chromatography and a suitable eluant.
For the use according to the invention of the compounds of formula I, or of compositions comprising them, there come into consideration all methods of application customary in agriculture, for example pre-emergence application, post-emergence application and seed dressing, and also various methods and techniques such as, for example, the controlled release of active ingredient. For that purpose a solution of the active ingredient is applied to mineral granule carriers or polymerised granules (urea/formaldehyde) and dried. If required, it is also possible to apply a coating (coated granules), which allows the active ingredient to be released in metered amounts over a specific period of time.
The compounds of formula I may be used as herbicides in their unmodified form, that is to say as obtained in the synthesis, but they are preferably formulated in customary manner together with the adjuvants conventionally employed in formulation technology, for example into emulsifiable concentrates, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules or microcapsules. Such formulations are described, for example, on pages 9 to 13 of WO 97/34485. As with the nature of the compositions, the methods of application, such as spraying, atomising, dusting, wetting, scattering or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
The formulations, that is to say the compositions, preparations or mixtures comprising the compound (active ingredient) of formula I or at least one compound of formula I and, usually, one or more solid or liquid formulation adjuvants, are prepared in known manner, e.g. by homogeneously mixing and/or grinding the active ingredients with the formulation adjuvants, for example solvents or solid carriers. Surface-active compounds (surfactants) may also be used in addition in the preparation of the formulations. Examples of solvents and solid carriers are given, for example, on page 6 of WO 97/34485.
Depending on the nature of the compound of formula I to be formulated, suitable surfaceactive compounds are non-ionic, cationic and/or anionic surfactants and surfactant mixtures having good emulsifying, dispersing and wetting properties. Examples of suitable anionic, non-ionic and cationic surfactants are listed, for example, on pages 7 and 8 of 2000 EP 009902313 -200. PH/5-30452/A -53- WO 97/34485.
In addition, the surfactants conventionally employed in formulation technology, which are described, inter alia, in "McCutcheon's Detergents and Emulsifiers Annual" MC Publishing Corp., Ridgewood New Jersey, 1981, Stache, "Tensid-Taschenbuch", Carl Hanser Verlag, Munich/Vienna 1981, and M. and J. Ash, "Encyclopedia of Surfactants", Vol. I-IIl, Chemical Publishing Co., New York, 1980-81, are also suitable for the preparation of the herbicidal compositions according to the invention.
The herbicidal formulations generally contain from 0.1 to 99 by weight, especially from 0.1 to 95 by weight, of herbicide, from 1 to 99.9 by weight, especially from 5 to 99.8 by weight, of a solid or liquid formulation adjuvant, and from 0 to 25 by weight, especially from 0.1 to 25 by weight, of a surfactant. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations. The compositions may also comprise further ingredients, such as stabilisers, for example vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rape oil or soybean oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders, tackifiers, and also fertilisers or other active ingredients.
The compounds of formula I or compositions comprising such compounds are generally applied to plants or the locus thereof at rates of application of from 0.001 to 4 kg/ha, especially from 0.005 to 2 kg/ha. The concentration required to achieve the desired effect can be determined by experiment. It is dependent on the nature of the action, the stage of development of the cultivated plant and of the weed and on the application (place, time, method) and may vary within wide limits as a function of those parameters.
The compounds of formula I are distinguished by herbicidal and growth-inhibiting properties, allowing them to be used in crops of useful plants, especially cereals, cotton, soybeans, sugar beet, sugar cane, plantation crops, rape, maize and rice, and also for non-selective weed control. The term "crops" is to be understood as including also crops that have been made tolerant to herbicides or classes of herbicides as a result of conventional methods of breeding or genetic techniques. The weeds to be controlled may be either monocotyledonous or dicotyledonous weeds, such as, for example, Stellaria, Nasturtium, Agrostis, Digitaria, Avena, Setaria, Sinapis, Lolium, Solanum, Echinochloa, Scirpus, Monochoria, Sagittaria, Bromus, Alopecurus, Sorghum halepense, Rottboellia, Cyperus, Abutilon, Sida, Xanthium, Amaranthus, Chenopodium, Ipomoea, Chrysanthemum, Galium, Viola and RA :.,Veronica.
AMENDED
SHEET
EP 009902313 1-20 nn PH/5-30452/A 65.. *e, -54- The following Examples further illustrate the invention.
Preparation Examples: Example P1: Preparation of 2-N-ethoxvcarbonylamino-3-fluoro-5-chloro-ovridine Cl F II
N."N/C\
N NH
OC
2 294 g of 2-amino-3-fluoro-5-chloro-pyridine are dissolved in 1 litre of dry pyridine and cooled to 0°C; 220 g of ethyl chloroformate are added dropwise, with stirring, and the mixture is stirred at 22°C until reaction is complete. The reaction mixture is then poured into ice-water, adjusted to pH 4-5 with 2N hydrochloric acid and extracted with ethyl acetate. The combined extracts are washed with water, dried over sodium sulfate, concentrated by evaporation and caused to crystallise by the addition of n-hexane. The resulting precipitate is filtered off, washed with n-hexane and dried in vacuo, yielding the desired title compound having a melting point of 132*C.
Example P2: Preparation of 1-(3-fluoro-5-chloro-pvridin-2-yl-3-methl-4-trifluoromethvlpyrimidine-2,6-dione Cl F N N NCH Under a nitrogen atmosphere, with cooling and stirring, a solution of 22.7 g of 4,4,4-trifluoro- 3-amino-2-butenoic acid ethyl ester is added dropwise at 0-5"C to 5.1 g of a previously prepared sodium hydride dispersion in 60 ml of N-methylpyrrolidine and the mixture is stirred at 22°C until the evolution of hydrogen has ceased. 23.7 g of 2- (Example P1) are then added and the reaction mixture is heated at 120°C for about 5 hours. The mixture is then cooled, 16.7 g of methyl iodide are added dropwise and stirring is carried out at 22°C overnight. The reaction mixture is taken up in ethyl acetate and then washed with ice-water, dried over sodium sulfate, filtered and concentrated by evaporation. The resulting residue is recrystallised from ethyl acetate/n-hexane, yielding the desired title compound having a melting point of 133- 134°C.
AMENDED
SHEET
WO 99/52893 PCT/EP99/02313 Example P3: Preparation of 1-(3-fluoro-5-chloro-2-pvridyl-N-oxide)-3-methyl-4trifluoromethvl-pyrimidine-2,6-dione Cl F NF ,CH, N+ N N O CF 3 24 g of 1-( 3 -fluoro-5-chloro-pyridin-2-yl)-3-methyl-4-trifluoromethyl-pyrimidine-2,6-dione (Example P2) in 150 ml of dichloromethane are cooled to -50C and 2 g of hydrogen peroxide/urea adduct are added. 2.7 ml of trifluoroacetic acid anhydride dissolved in 2 ml of dichloromethane are then metered in dropwise and after the exothermic reaction has subsided the reaction mixture is stirred overnight to complete the reaction. A further 5 g of hydrogen peroxide/urea adduct and 3 ml of trifluoroacetic acid anhydride are then added in two portions in the course of 3 hours and after the exothermic reaction has subsided the reaction mixture is heated at 25-35 0 C until the reaction is complete. The reaction mixture is then cooled and at -5 0 C adjusted to pH 7.5 first with 2N sodium hydroxide solution and then with saturated sodium hydrogen carbonate solution and partitioned between dichloromethane and ice-water; the organic phase is separated off, dried over sodium sulfate, filtered and concentrated by evaporation. The solid residue that remains is recrystallised from ethyl acetate/n-hexane, yielding the desired product having a melting point of 142- 143 0
C.
Example P4: Preparation of 1-( 3 -fluoro-5.6-dichloro-2-pyridyl)-3-methvl-4-trifluoromethylpyrimidine-2,6-dione CI F CimN< ,A ,CH3 CI N NJ NCH3 0 C F 3 6.8 g of 1-( 3 -fluoro-5-chloro- 2 -pyridyl-N-oxide)-3-methyl-4-trifluoromethyl-pyrimidine-2,6dione (Example P3) are added in portions to a solution, heated to 700C, of 2.4 ml of phosphorus oxytrichloride in 20 ml of 1,2-dichloroethane and the mixture is maintained at that temperature overnight; a further 4.0 ml of phosphorus oxytrichloride is added and the mixture is heated for a further 20 hours. The mixture is then cooled, poured into ice-water and extracted with dichloroethane and the combined extracts are washed with ice-cold 2N WO 99/52893 PCT/E P99/023 13 -56sodium hydroxide solution and water, dried over sodium sulfate and concentrated by evaporation. The residue is purified by means of silica gel chromatography (eluant: hexane/ethyl acetate yielding the desired title compound having a melting point of 113-1150C.
Example P5: Preparation of 1-(2-hvdroxy-3-chloro-5-fluoro-pyridin-6-yl)-3-methyl-4trifluoromethvl-pyrimidine-2.6-dione Cl F HO N N N H 0 -CF 3 182 g of trifluoroacetic acid anhydride are added dropwise to a solution, cooled to -300C, of 29.6 g of 1-(3-fluoro-5-chloro-2-pyridyl-N-oxide)-3-methyl-4-trifluoromethyl-pyrimidine-2,6dione (Example P3) in 400 ml of dimethylformamide and the mixture is then stirred overnight at -30C and on the following day at 22°C. The mixture is then freed of excess trifluoroacetic acid anhydride in vacuo, cooled to -5°C and cautiously neutralised first with dilute sodium hydroxide solution and then with sodium hydrogen carbonate solution. After the addition of ice-water, extraction is carried out with ethyl acetate and the combined extracts are washed with water and dried over sodium sulfate. Filtration is then carried out and the filtrate is concentrated by evaporation; the resulting residue is purified over a column of silica gel (eluant: n-hexane/ethyl acetate 8/2, with an increasing gradient with respect to ethyl acetate). The desired title compound having a melting point of 178 0 C is obtained.
WO 99/52893 PCT/EP99/02313 -57 Examp~le P6: Preparation of 1 2 -Droparavlox~y-3-chloro-5-fluoro-Dvyridin-6-yl)-3-methyl4.
trifluoromethvl-pvrimidine-2.6-dione, 1 -(2-chloro-3-D~ropargyloxy-5-fluoro-pvridin-6-yl)-3 m ethvl-4-trif Iuoromethyl -gvrimid in e-2 .6-d ion e and 1 -Droparpvloxv-3-chloro-5-fluoro-2- Dvyridon-6-yl)-3-methyl-4-trif luoromethyl-pyrimidine-2,6dione CI F
HCH
CH CH 2 N FN 3 N N N 3
C
M
CF
3 CH03 CI
F
0
CHCH
/H
CF
3 C 0
CH
ml of propargyl bromide are added dropwise to a suspension of 10.2 g of a mixture of 1and 1l-( 2 -ch loro-3-hyd roxy-5-flIuo ro-pyridi n-6-yl)-3-methyl-4trif luoromethyl..pyri mid ine-2,6dione (Example P5), 7.5 g of potassium carbonate and 0.08 g of 18B-crown-6 in 180 ml of acetonitrile and the mixture is then heated at 6500 overnight. Concentration by evaporation in vacua is then carried out, and an ethyl acetate/ice-water mixture and 1 N hydrochloric acid are added to the resulting residue until a pH of 7 is obtained; the aqueous phase is separated off and extracted with ethyl acetate and the combined organic phases are washed with water, dried over sodium sulfate, filtered and concentrated by evaporation.
The residue is purified by silica gel chromatography (eluant: n-hexane/ethyl acetate 8/2), yielding the desired isomers 1 2 -propargyloxy-3-chloro-5-fluoro-pyridin-6-y)-3-methyl-4trif luo romethyl-pyrimid ine-2,6-d ion e having a melting point of 121-122'C, 1-(2-chloro-3prpryoy5fur-ydn6y)3mty--~~ooehlprmdn-,-in having a melting point of 69-71 OC and 1 -propargyloxy-3-chloro-5-f luoro-2-pyridon.6yl)-3-methyl-4trifluoromethyl-pyrimidine-2,6-dione having a melting point of 223-224 0
C.
WO 99/52893 PCT/EP99/02313 -58- Example P7: Preparation of 1-(1-allvloxy-3-chloro-5-fluoro-2-pridon-6-vl)-3-methyl4trifluoromethvl-pyrimidine-2.6-dione CI F 1 T0 0 N N N
H
C-CH2 CF3
H,
2
C
A solution of 0.62 g of 1-( 2 -allyloxy-3-chloro-5-fluoro-pyridin-6-yl)-3-methyl-4-trifluoromethylpyrimidine-2,6-dione in 5 ml of dioxane is stirred at 20 0 C with 0.02 g of palladium(ll) chloride/diacetonitrile complex until reaction is complete. The reaction mixture is then filtered over silica gel and concentrated by evaporation. The title compound is purified by silica gel chromatography (eluant: ethyl acetate/hexane). The title compound is obtained in pure form with a melting point of 115-117°C.
Example P8: Preparation of 2-(5-chloro-3-fluoro-1-oxv-pyridin-2-vl)-4.5,6.7-tetrahvdroisoindolo-1,3-dione (intermediate) CIF 0 N N
I-
With cooling at -250 to -15OC, 15 g of trifluoroacetic acid anhydride are added in the course of 30 minutes to a suspension of 10.1 g of 2-(5-chloro-3-fluoro-pyridin-2-yl)-4,5,6,7-tetrahydroisoindolo-1,3-dione (prepared analogously to Chem. Abstr. 114, 164251f) and 6.6 g of hydrogen peroxide/urea adduct in 100 ml of 1,2-dichloroethane. Stirring is carried out at 0 C overnight, and then a further 3.3 g of hydrogen peroxide/urea adduct is added and stirring is continued at 20 0 C until reaction is complete. Everything is then poured into icewater and neutralised with aqueous 2N sodium hydroxide solution. The product is extracted with ethyl acetate, washed with water and dried. Concentration by evaporation yields a solid, which is purified by means of silica gel chromatography (eluant: hexane/ethyl acetate The desired 2-(5-chloro-3-fluoro-1-oxy-pyridin-2-yl)-4,5,6,7-tetrahydroisoindolo-1,3dione having a melting point of 162-164°C is obtained.
WO 99/52893 PCT/E P99/02313 -59- Example P9: Preparation of 2-(5-chloro-3-fluoro-6-hydroxy-pyridin-2-l)-4.5,6.7-tetrahydroisoindolo-1.3-dione and 2-(5-hvdrox-6-chloro-3-fluoro-pyridin-2-yl)-4.5,6,7-tetrahydroisoindolo-1,3-dione CI F HO F 0 0 HO N N and CI N N O /O 3.6 ml of trifluoroacetic acid anhydride are added dropwise, with cooling at -300 to -20°C, to a solution of 0.79 g of 2-(5-chloro-3-fluoro-1-oxy-pyridin-2-yl)-4,5,6,7-tetrahydroisoindolo- 1,3-dione (Example P8) in 12 ml of dimethylformamide and the mixture is stirred at +10 C overnight. A further 3 ml of trifluoroacetic acid anhydride is then added dropwise and stirring is continued at +10 0 C for 15 hours. Concentration by evaporation is then carried out; ethyl acetate is added to the resulting residue and the mixture is rendered basic with aqueous 1N sodium hydroxide solution. Extraction is then carried out with ethyl acetate and the combined extracts are washed with water, dried and concentrated by evaporation. The residue is purified by silica gel chromatography, yielding the isomeric mixture of the two title compounds having a melting point of 190-193 0 C. The mixture can either be separated or further reacted directly.
In an analogous manner, and in accordance with methods as shown in the general Reaction Schemes 1-10 and in the references indicated, it is also possible to obtain the preferred compounds listed in the following Tables.
Table 1: A preferred group of compounds of formula I corresponds to general formula Ro 1 Cl N F wherein the meanings of the corresponding N -N F X R 3 O CH 3 substituents R1, X, and R 3 are given in Table A, so that 423 specific compounds of formula I, are disclosed.
WO 99/52893 PCT/EP99/02313 Table 2: A further preferred group of compounds of formula I corresponds to general R.o formula Br- -N F wherein the meanings of the corresponding N -N
F
X R, 0 CH 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 12 are disclosed.
Table 3: A further preferred group of compounds of formula I corresponds to general Ro0 formula NC N F wherein the meanings of the corresponding N hN F X 1 R 3 o CH 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 13 are disclosed.
Table 4: A further preferred group of compounds of formula I corresponds to general
R,
1 0 formula CH 3 N F wherein the meanings of the N -N F X R 3 O CH corresponding substituents R 1
X
1 and Ra are indicated in Table A, so that 423 specific compounds of formula 14 are disclosed.
Table 5: A further preferred group of compounds of formula I corresponds to general Rio
F
formula Cl N F wherein the meanings of the corresponding N N F X R 3 s CH 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 15 are disclosed.
WO 99/52893 PCT/EP99/02313 -61 Table 6: A further preferred group of compounds of formula I corresponds to general R 1 formula CI- N F wherein the meanings of the corresponding -N F X R 3 CH 3 substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 16 are disclosed.
Table 7: A further preferred group of compounds of formula I corresponds to general
R
1 0
FF
formula Cl N F wherein the meanings of the N >N F F X R, 0 CH 3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 17 are disclosed.
Table 8: A further preferred group of compounds of formula I corresponds to general R S
F\
formula Cl N F wherein the meanings of the corresponding N F X R 3 S CH, substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula le are disclosed.
Table 9: A further preferred group of compounds of formula I corresponds to general
R
1 0
FF
formula CH 3 N F wherein the meanings of the N N FF X R 3 0 CH, corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 19 are disclosed.
WO 99/52893 PCTIE P99/02313 -62- Table 10: A further preferred group of compounds of formula I corresponds to general
R
1 o Cl
F
formula C N H (11o), wherein the meanings of the corresponding NN
F
N. N
F
X R 30 CHF substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula I10 are disclosed.
Table 11: A further preferred group of compounds of formula I corresponds to general
R
1 0 CH, /f F formula CI -N F (111), wherein the meanings of the corresponding N -N F X R 3 o CH substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula Il, are disclosed.
Table 12: A further preferred group of compounds of formula I corresponds to general R 0 Cl formula Cl N F (112), wherein the meanings of the corresponding N #N F X R 30 CH, substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 112 are disclosed.
Table 13: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula Cl R N CN (113), wherein the meanings of the corresponding X R 30 CH 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 113 are disclosed.
WO 99/52893 PCT/EP99/0231 3 -63- Table 14: A further preferred group of compounds of formula I corresponds to general R 0
CH,
yry 3 formula Br N CN (114), wherein the meanings of the corresponding N fN, X R 3 CH 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 114 are disclosed.
Table 15: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula NC RN CN wherein the meanings of the corresponding N N\ X 1 R 3 o
CH
3 substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 115 are disclosed.
Table 16: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula CH 3 N -CN (116), wherein the meanings of the corresponding N
N
X R 3 CH, substituents X 1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 116 are disclosed.
Table 17: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula Cl N (117), wherein the meanings of the corresponding N -N X R 3 CH 3 substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 117 are disclosed.
WO 99/52893 PCT/EP99/02313 -64- Table 18: A further preferred group of compounds of formula I corresponds to general formula Cl (118), wherein the meanings of the corresponding X R 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula lia are disclosed.
Table 19: A further preferred group of compounds of formula I corresponds to general Ro formula Cl N I wherein the meanings of the corresponding N
*N
X R3 S substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 119 are disclosed.
Table 20: A further preferred group of compounds of formula I corresponds to general R CH 3
F
formula Cl/ -N -F (120), wherein the meanings of the corresponding N N- F X R3 CH 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 120 are disclosed.
Table 21: A further preferred group of compounds of formula I corresponds to general formula Cl F wherein the meanings of the corresponding X R
A
1 -3
CH
3 substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 121 are disclosed.
WO 99/52893 PCT/EP99/02313 Table 22: A further preferred group of compounds of formula I corresponds to general Rio S\ F formula Br N F (i22), wherein the meanings of the N N- F X R 3 CH 3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 122 are disclosed.
Table 23: A further preferred group of compounds of formula I corresponds to general formula F (123), wherein the meanings of the corresponding 1 ;/R 3
CH,
substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 123 are disclosed.
Table 24: A further preferred group of compounds of formula I corresponds to general formula meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 124 are disclosed.
Table 25: A further preferred group of compounds of formula I corresponds to general formula F (125), wherein the meanings of the corresponding X R 1 3 substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 125 are disclosed.
WO 99/52893 PCT/E P99/02313 -66- Table 26: A further preferred group of compounds of formula I corresponds to general
CH
3
R
1 0
F
formula Br N F (126), wherein the meanings of the N N
F
X R3 corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 126 are disclosed.
Table 27: A further preferred group of compounds of formula I corresponds to general R0, formula N (127), wherein the meanings of N N F X -F Xl
R
3 the corresponding substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 127 are disclosed.
Table 28: A further preferred group of compounds of formula I corresponds to general
CH
3
R
1 0
F
formula N F (128), wherein the meanings of the N N-
F
Xi R3 corresponding substituents Ri, X 1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 12e are disclosed.
Table 29: A further preferred group of compounds of formula I corresponds to general
R
1 o Cl
F
formula Cl N F (129), wherein the meanings of the corresponding N N- F X R3 CH 3 substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 129 are disclosed.
WO 99/52893 PCT/EP99/02313 -67- Table 30: A further preferred group of compounds of formula I corresponds to general R 1S
CH
3 formula C (130), wherein the meanings of the corresponding N N F X 1 R3 H 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 130 are disclosed.
Table 31: A further preferred group of compounds of formula I corresponds to general formula (131), wherein the meanings of the corresponding X R substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 131 are disclosed.
Table 32: A further preferred group of compounds of formula I corresponds to general formula (132), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 132 are disclosed.
Table 33: A further preferred group of compounds of formula I corresponds to general
RS
F
formula N
F
formula N- F wherein the meanings of the corresponding X
R
3
CH
3 substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 133 are disclosed.
WO 99/52893 PCT/EP99/02313 -68- Table 34: A further preferred group of compounds of formula I corresponds to general Rio formula C (134), wherein the meanings of the corresponding N N F X
"R
3 substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 134 are disclosed.
Table 35: A further preferred group of compounds of formula I corresponds to general R S
F
formula CH F (13s), wherein the meanings of the corresponding N N F X
R,
substituents R 1
X
1 and R3 are indicated in Table A, so that 423 specific compounds of formula 135 are disclosed.
Table 36: A further preferred group of compounds of formula I corresponds to general R,0 formula N N (136), wherein the meanings of the N N- F corresponding substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 136 are disclosed.
Table 37: A further preferred group of compounds of formula I corresponds to general R 0 C l
F
formula Cl N F (137), wherein the meanings of the corresponding N N= F X R 3
CN
sdbstituents X, and Ra are indicated in Table A, so that 423 specific compounds of formula 137 are disclosed.
WO 99/52893 PCT/E P99/0231 3 -69- Table 38: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula CI N F (138), wherein the meanings of the N N F X R3 Cl corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula la1 are disclosed.
Table 39: A further preferred group of compounds of formula I corresponds to general R 1 cl formula Cl N F (139), wherein the meanings of the corresponding N N- F X R, Cl substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 139 are disclosed.
Table 40: A further preferred group of compounds of formula I corresponds to general
R
1 0 NC N F formula N N- F (140), wherein the meanings of the X1 R, 3
CH
3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 140 are disclosed.
Table 41: A further preferred group of compounds of formula I corresponds to general R0o formula Cl N N (141), wherein the meanings of the corresponding N Nxf R, substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 141 are disclosed.
WO 99/52893 PCT/EP99/02313 Table 42: A further preferred group of compounds of formula I corresponds to general
RS
formula Cl I~ N (142), wherein the meanings of the corresponding N Nsubstituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 142 are disclosed.
Table 43: A further preferred group of compounds of formula I corresponds to general formula Cl (143), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 143 are disclosed.
Table 44: A further preferred group of compounds of formula I corresponds to general formula NC (144), wherein the meanings of the corresponding X R substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 144 are disclosed.
Table 45: A further preferred group of compounds of formula I corresponds to general
R
1
CH
3 Br formula Cl N (145), wherein the meanings of the corresponding N N
CH
3
X
1 R 3 substituents RI, X, and Ra are indicated in Table A, so that 423 specific compounds of formula 145 are disclosed.
WO 99/52893 PCT/EP99/02313 -71 Table 46: A further preferred group of compounds of formula I corresponds to general
R,
formula CI
N
N N H, X R3 (146), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 146 are disclosed.
Table 47: A further preferred group of compounds of formula I corresponds to general R 1 CF 3 formula CI N (147), wherein the meanings of the corresponding N N CH 3 X R3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 147 are disclosed.
Table 48: A further preferred group of compounds of formula I corresponds to general R 1 CI formula NC CH (148), wherein the meanings of the corresponding N N
CH
3 xf R3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 148 are disclosed.
Table 49: A further preferred group of compounds of formula I corresponds to general formula CI (149), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 149 are disclosed.
WO 99/52893 PCT/E P99/02313 -72- Table 50: A further preferred group of compounds of formula I corresponds to general R 1 CH 3 COOEt formula C N wherein the meanings of the corresponding N N CH 3 X R3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 150 are disclosed.
Table 51: A further preferred group of compounds of formula I corresponds to general R 1
N
2 formula CI N CH (Is5), wherein the meanings of the corresponding X; R, N N- Cl substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula Is1 are disclosed.
Table 52: A further preferred group of compounds of formula I corresponds to general R 1 C 2
H
formula CI N H (152), wherein the meanings of the corresponding N N C 2
H
X; R, substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 152 are disclosed.
Table 53: A further preferred group of compounds of formula I corresponds to general R 1 C 2
H,
formula CI/ (1ss), wherein the meanings of the corresponding N N C2H X; R, substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 153 are disclosed.
WO 99/52893 PCTIEP99/02313 -73- Table 54: A further preferred group of compounds of formula I corresponds to general R 1
NO,
formula NC N~ CH-N (s54), wherein the meanings of the corresponding N. N CH 3 X
R,
substituents R 1
X
1 and Ra are indicated in Table A, so that 423 specific compounds of formula 154 are disclosed.
Table 55: A further preferred group of compounds of formula I corresponds to general
R
1 formula CI N CH\ (Iss), wherein the meanings of the corresponding N N CCH 3 X1
R
3 substituents R 1 Xi and R 3 are indicated in Table A, so that 423 specific compounds of formula Iss are disclosed.
Table 56: A further preferred group of compounds of formula I corresponds to general R 1 C 2 Hs N, Br formula CI/ N (Is6), wherein the meanings of the corresponding N N "CH 3 X; R3 substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 156 are disclosed.
Table 57: A further preferred group of compounds of formula I corresponds to general R 1 NH formula Cl N (157), wherein the meanings of the corresponding N. N CH 3 X; R3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 157 are disclosed.
WO 99/52893 PCT/EP99/02313 -74- Table 58: A further preferred group of compounds of formula I corresponds to general
CH
3 1 CH N R1 N formula wherein the meanings of the corresponding Cl
N'-
N N CCH 3 X, R 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 158 are disclosed.
Table 59: A further preferred group of compounds of formula I corresponds to general R 1 NO, formula Cl wherein the meanings of the corresponding N N
C
2 Hs X '1 '3 X, R substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 159 are disclosed.
Table 60: A further preferred group of compounds of formula I corresponds to general
R
1 Cl formula Cl -N 1 (160), wherein the meanings of the corresponding N N__o
X
1 R 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 160 are disclosed.
Table 61: A further preferred group of compounds of formula I corresponds to general R CN formula CI 1 N (161), wherein the meanings of the corresponding N N X;
R,
substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 161 are disclosed.
WO 99/52893 PCT/EP99/02313 Table 62: A further preferred group of compounds of formula I corresponds to general R Ci formula NC NN (162), wherein the meanings of the corresponding N
N:O
XI R 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 162 are disclosed.
Table 63: A further preferred group of compounds of formula I corresponds to general R Cl formula Cl N N (163), wherein the meanings of the N N3: X R, corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 163 are disclosed.
Table 64: A further preferred group of compounds of formula I corresponds to general R CI formula NC N N J (164), wherein the meanings of the N N Xf R, corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 164 are disclosed.
Table 65: A further preferred group of compounds of formula I corresponds to general R Cl formula Cl -N (165), wherein the meanings of the v ;N N X'
R
3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 165 are disclosed.
WO 99/52893 PCT/EP99/0231 3 -76- Table 66: A further preferred group of compounds of formula I corresponds to general R 1 Cl formula Cl N
N
(166), wherein the meanings of the N
N:
XI
R
3 corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 166 are disclosed.
Table 67: A further preferred group of compounds of formula I corresponds to general R 1 CH 3 RIOCHH formula ClI/ N (167), wherein the meanings of the N N X1 R 3 corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 167 are disclosed.
Table 68: A further preferred group of compounds of formula I corresponds to general
F
R1 formula Cl N (168), wherein the meanings of the N
N
X1 R3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 168 are disclosed.
Table 69: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula C N CH (169), wherein the meanings of the N CH3 X; R 3 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 169 are disclosed.
WO 99/52893 PCT/E P99/02313 -77- Table 70: A further preferred group of compounds of formula I corresponds to general Ro
CH
formula CH 3 -N (170), wherein the meanings of the corresponding N
C/H
3 X, R3 O substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 170 are disclosed.
Table 71: A further preferred group of compounds of formula I corresponds to general
R,
1
CH,
formula NC N (171), wherein the meanings of the corresponding N
C
Xf R, O substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 171 are disclosed.
Table 72: A further preferred group of compounds of formula I corresponds to general R,0 Cl formula Cl N (172), wherein the meanings of the
N
CH
3
X
1 R 3 corresponding substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 172 are disclosed.
Table 73: A further preferred group of compounds of formula I corresponds to general Ro CF3 formula NC N (173), wherein the meanings of the corresponding N CF 3 XI R3 O substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 173 are disclosed.
WO 99/52893 PCT/EP99/02313 -78- Table 74: A further preferred group of compounds of formula I corresponds to general formula Cl (174), wherein the meanings of the corresponding
X
1 R S substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 174 are disclosed.
Table 75: A further preferred group of compounds of formula I corresponds to general Ro
CH
formula NC N (175), wherein the meanings of the corresponding N
CH,
3 X, R,
O
substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 17s are disclosed.
Table 76: A further preferred group of compounds of formula I corresponds to general Ro formula Cl N (176), wherein the meanings of the corresponding N
CH
3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 176 are disclosed.
Table 77: A further preferred group of compounds of formula I corresponds to general
R
1 formula Cl N wherein the meanings of the corresponding
N
X1 R3 0 substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 17 are disclosed.
WO 99/52893 PCT/EP99/02313 -79- Table 78: A further preferred group of compounds of formula I corresponds to general formula Cl (178), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 178 are disclosed.
Table 79: A further preferred group of compounds of formula I corresponds to general
R,
formula Cl N (179), wherein the meanings of the corresponding N
CF
3
X
1 R, S substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 179 are disclosed.
Table 80: A further preferred group of compounds of formula I corresponds to general formula Cl (18o), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula leo are disclosed.
Table 81: A further preferred group of compounds of formula I corresponds to general R o formula Cl N wherein the meanings of the corresponding
N
X N R, 0 substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula s18 are disclosed.
WO 99/52893 PCT/EP99/02313 Table 82: A further preferred group of compounds of formula I corresponds to general Ro formula CH 3 N (182), wherein the meanings of the corresponding
N
X, R, o substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 182 are disclosed.
Table 83: A further preferred group of compounds of formula I corresponds to general Ro formula NC N (183), wherein the meanings of the corresponding
N
X1 R3 o substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 183 are disclosed.
Table 84: A further preferred group of compounds of formula I corresponds to general Ro
CI
formula Cl N
N
X R 3 o (184), wherein the meanings of the corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula I are disclosed.
Table 85: A further preferred group of compounds of formula I corresponds to general formula (las), wherein the meanings of the corresponding substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula las are disclosed.
WO 99/52893 PCT[E P99/0231 3 -81 Table 86: A further preferred group of compounds of formula I corresponds to general formula CI (lae), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 186 are disclosed.
Table 87: A further preferred group of compounds of formula I corresponds to general Ro
CH
3 formula NC N
N
X, R, o (187), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 187 are disclosed.
Table 88: A further preferred group of compounds of formula I corresponds to general R,o ';rl CI X 1 NRCH 3 formula Cl N
H
N
X1 R 3 0 (188), wherein the meanings of the corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 188 are disclosed.
Table 89: A further preferred group of compounds of formula I corresponds to general R,o
CH
3 formula Br N
N
X; R 3 0 wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula la1 are disclosed.
WO 99/52893 PCT/E P99/02313 -82- Table 90: A further preferred group of compounds of formula I corresponds to general R S formula CI N (190), wherein the meanings of the corresponding
N
X; R, S substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 190 are disclosed.
Table 91: A further preferred group of compounds of formula I corresponds to general Ro formula Cl N (191), wherein the meanings of the N. -CH 3 X; R, O corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 191 are disclosed.
Table 92: A further preferred group of compounds of formula I corresponds to general RO0
CH
formula CI N l (192), wherein the meanings of the corresponding X, R, o 1
R
3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 192 are disclosed.
Table 93: A further preferred group of compounds of formula I corresponds to general R, 0
NH
formula Cl N J (193), wherein the meanings of the corresponding X N R Xi R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 193 are disclosed.
WO 99/52893 PCTIEP99/02313 -83- Table 94: A further preferred group of compounds of formula I corresponds to general Ri0O ,CH3 formula Cl N\ wherein the meanings of the corresponding
N
X R 3
CH
3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 194 are disclosed.
Table 95: A further preferred group of compounds of formula I corresponds to general R 1
/NCH,
formula Cl N J9-N (195), wherein the meanings of the corresponding
X
i R 0 CH2CH substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 19 are disclosed.
Table 96: A further preferred group of compounds of formula I corresponds to general RO 0 N CH, formula Cl N J (196), wherein the meanings of the
X
1 R 3 CH 2
CH
2
CH
3 corresponding substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 196 are disclosed.
Table 97: A further preferred group of compounds of formula I corresponds to general R0 formula Cl N/ (197), wherein the meanings of the N Y\ X R 3 H CH2CH2CH 3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 197 are disclosed.
WO 99/52893 PCT/EP99/02313 -84- Table 98: A further preferred group of compounds of formula I corresponds to general formula Cl (198), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 198 are disclosed.
Table 99: A further preferred group of compounds of formula I corresponds to general formula (199), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 199 are disclosed.
Table 100: A further preferred group of compounds of formula I corresponds to general
,,CH
2
CH
3 formula the meanings of the corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula Iloo are disclosed.
Table 101: A further preferred group of compounds of formula I corresponds to general formula CI (1li0), wherein the meanings of the
CH
2
CH
2
CH
3 corresponding substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula lo, are disclosed.
WO 99/52893 PCT/EP99/02313 Table 102: A further preferred group of compounds of formula I corresponds to general formula CI- (1102), wherein the meanings of the corresponding xi R 3
S
CH
3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1102 are disclosed.
Table 103: A further preferred group of compounds of formula I corresponds to general N 1 ,~CH, formula NC N CH 3 CH (o103), wherein the meanings of the corresponding X, R 3
CH
3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1103 are disclosed.
Table 104: A further preferred group of compounds of formula I corresponds to general
R
1 /F kNCH3 formula (1104), wherein the meanings of the corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1104 are disclosed.
Table 105: A further preferred group of compounds of formula I corresponds to general
R
1 0 ,N %NCH3 formula (lios), wherein the meanings of the corresponding substituents Ri, X, and Rs are indicated in Table A, so that 423 specific compounds of formula Ios are disclosed.
WO 99/52893 PCT/EP99/02313 -86- Table 106: A further preferred group of compounds of formula I corresponds to general R1 o NCH3 formula c N /R C (11o6), wherein the meanings of the 1 3 CH 3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula Ilo0 are disclosed.
Table 107: A further preferred group of compounds of formula I corresponds to general
R
1
S
/N
CH
3 formula Br N (1107), wherein the meanings of the corresponding
X
1 R3S
H
3 substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1107 are disclosed.
Table 108: A further preferred group of compounds of formula I corresponds to general
R
1 C N CH3 Cl N formula N wherein the meanings of the corresponding X R 3
O
substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula lios are disclosed.
Table 109: A further preferred group of compounds of formula I corresponds to general R O formula Cl -N (11o), wherein the meanings of the corresponding X, R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula lio9 are disclosed.
WO 99/52893 PCT/EP99/02313 -87- Table 110: A further preferred group of compounds of formula I corresponds to general RO0 formula Cl N (111o), wherein the meanings of the corresponding
N
X, R3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 111o are disclosed.
Table 111: A further preferred group of compounds of formula I corresponds to general R o formula C- N wherein the meanings of the N OH X, R3 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula Ii, are disclosed.
Table 112: A further preferred group of compounds of formula I corresponds to general R O0 formula Cl- N (1112), wherein the meanings of the
N
C1 X, R 3 0 corresponding substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1112 are disclosed.
Table 113: A further preferred group of compounds of formula I corresponds to general R o formula Br N wherein the meanings of the CN l X, R o0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula I113 are disclosed.
WO 99/52893 PCT/EP99/02313 -88- Table 114: A further preferred group of compounds of formula I corresponds to general Ri 0 formula NC N (1114), wherein the meanings of the
N
Cl X R 3 0 corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1114 are disclosed.
Table 115: A further preferred group of compounds of formula I corresponds to general formula NC N (111 wherein the meanings of the corresponding
N
X, R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1115 are disclosed.
Table 116: A further preferred group of compounds of formula I corresponds to general formula Br I-N (1116), wherein the meanings of the corresponding N F
F
X, R, 0 substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1116 are disclosed.
Table 117: A further preferred group of compounds of formula I corresponds to general formula CI N (1117), wherein the meanings of the corresponding N F X, R 3 o substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1117 are disclosed.
WO 99/52893 PCT/E P99/0231 3 -89- Table 118: A further preferred group of compounds of formula I corresponds to general R o formula Cl N F (111), wherein the meanings of the corresponding N
F
F
X, R, 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula In are disclosed.
Table 119: A further preferred group of compounds of formula I corresponds to general R 0 formula NC N \F (1119), wherein the meanings of the
N
F
X, R 3 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1119 are disclosed.
Table 120: A further preferred group of compounds of formula I corresponds to general R1 S formula NC N F (1120), wherein the meanings of the
N
X R 3 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1120 are disclosed.
Table 121: A further preferred group of compounds of formula I corresponds to general
RS
formula ClI N F (1121), wherein the meanings of the corresponding N N F X, R 3
S
substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1121 are disclosed.
WO 99/52893 PCT/EP99/02313 Table 122: A further preferred group of compounds of formula I corresponds to general formula
O
O CH 3 (1122), wherein the meanings of the corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1122 are disclosed.
Table 123: A further preferred group of compounds of formula I corresponds to general formula CI N (1123), wherein the meanings of the N
H
X, R 0 OO CH 3 corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1123 are disclosed.
Table 124: A further preferred group of compounds of formula I corresponds to general R 0 formula Br N H (1124), wherein the meanings of the N
CH
Xi R 3 o corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1124 are disclosed.
Table 125: A further preferred group of compounds of formula I corresponds to general R1 o formula C l N.N C (112s), wherein the meanings of the
X
1
R
3 0 corresponding substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1125 are disclosed.
WO 99/52893 PCT/EP99/02313 -91 Table 126: A further preferred group of compounds of formula I corresponds to general R O formula Br N I (1126), wherein the meanings of the N
F
X R 3 0 F corresponding substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1126 are disclosed.
Table 127: A further preferred group of compounds of formula I corresponds to general R100 formula Cl N (127), wherein the meanings of the corresponding X, R3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1127 are disclosed.
Table 128: A further preferred group of compounds of formula I corresponds to general N o formula Cl- N \O (1128), wherein the meanings of the N 0
Y
X I R3 o CH3 corresponding substituents X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1128 are disclosed.
Table 129: A further preferred group of compounds of formula I corresponds to general RI0 formula CI N 1 (1129), wherein the meanings of the corresponding
N
X, R3 substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1129 are disclosed.
WO 99/52893 PCT/EP99/02313 -92- Table 130: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula Cl N (1130), wherein the meanings of the
N
X
1
R
3 corresponding substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1130 are disclosed.
Table 131: A further preferred group of compounds of formula I corresponds to general formula C- N N (131), wherein the meanings of the corresponding N F Xi R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1131 are disclosed.
Table 132: A further preferred group of compounds of formula I corresponds to general R 0 formula Cl- N F (1132), wherein the meanings of the X, R, 0 1 a 3 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1132 are disclosed.
Table 133: A further preferred group of compounds of formula I corresponds to general R 0 formula NC -N F (1133), wherein the meanings of the X, R 3 corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1133 are disclosed.
WO 99/52893 PCT/EP99/02313 -93- Table 134: A further preferred group of compounds of formula I corresponds to general Ri 0 formula CH 3 N)N F (1134), wherein the meanings of the N N X, R 3 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1134 are disclosed.
Table 135: A further preferred group of compounds of formula I corresponds to general RO0 formula Cl -N (1135), wherein the meanings of the corresponding X, R3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1135 are disclosed.
Table 136: A further preferred group of compounds of formula I corresponds to general R O formula Cl N O (1136), wherein the meanings of the corresponding X, R o substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1136 are disclosed.
Table 137: A further preferred group of compounds of formula I corresponds to general R, O formula Cl N (1137), wherein the meanings of the
N
X, R3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1137 are disclosed.
WO 99/52893 PCT/EP99/02313 -94- Table 138: A further preferred group of compounds of formula I corresponds to general R, o0 formula Cl N C/ (1138), wherein the meanings of the
N
X, R, 3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1138 are disclosed.
Table 139: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula Cl -N ,F (1139), wherein the meanings of the
N
X, R 3 o corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1139 are disclosed.
Table 140: A further preferred group of compounds of formula I corresponds to general RI S
NH
formula Cl I N (1140), wherein the meanings of the corresponding N -CH3 X, R 3
S
substituents R 1 Xi and R 3 are indicated in Table A, so that 423 specific compounds of formula 1140 are disclosed.
Table 141: A further preferred group of compounds of formula I corresponds to general R O formula CI N (1141), wherein the meanings of the N N CH3 X, R 3
O
corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1141 are disclosed.
WO 99/52893 PCT/E P99/02313 Table 142: A further preferred group of compounds of formula I corresponds to general Rio
N
formula Cl N (1142), wherein the meanings of the N N-CH
X
1 R, o corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1142 are disclosed.
Table 143: A further preferred group of compounds of formula I corresponds to general R 0 /N CH 3 formula Cl N 1 (1143), wherein the meanings of the N NCH, N 3 X, R3 0 corresponding substituents Ri, X 1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1143 are disclosed.
Table 144: A further preferred group of compounds of formula I corresponds to general R, o
N
formula CH, N (144), wherein the meanings of the rN NCH, x, R 3 0 corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1144 are disclosed.
Table 145: A further preferred group of compounds of formula I corresponds to general
R
1
S
formula Cl N 1 (1145), wherein the meanings of the N N' CH
X
1 R3 s corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1145 are disclosed.
WO 99/52893 PCT/EP99/02313 -96- Table 146: A further preferred group of compounds of formula I corresponds to general R O formula Cl N 1 (1146), wherein the meanings of the corresponding X, R 3
O
substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1146 are disclosed.
Table 147: A further preferred group of compounds of formula I corresponds to general
R
1 0 formula CI N I (1147), wherein the meanings of the corresponding X, R3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1147 are disclosed.
Table 148: A further preferred group of compounds of formula I corresponds to general R O C H 3 /a CNCH3 formula CI N I (1148), wherein the meanings of the N \CH X, R 3
O
corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1148 are disclosed.
Table 149: A further preferred group of compounds of formula I corresponds to general formula NC N 1N (1149), wherein the meanings of the corresponding
X
1
R
3
O
substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1149 are disclosed.
WO 99/52893 PCT/EP99/02313 -97- Table 150: A further preferred group of compounds of formula I corresponds to general RO0 formula Cl N N (115s), wherein the meanings of the corresponding N
I
X, R3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 115o are disclosed.
Table 151: A further preferred group of compounds of formula I corresponds to general formula CH 3 N (1s51), wherein the meanings of the corresponding fN
IN
X, R 3 o substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula li,5 are disclosed.
Table 152: A further preferred group of compounds of formula I corresponds to general R 0 formula Cl N I S (1152), wherein the meanings of the N IN X, R, 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1152 are disclosed.
Table 153: A further preferred group of compounds of formula I corresponds to general R 0 formula Cl IN I S (1153), wherein the meanings of the corresponding N N X, R, 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1153 are disclosed.
WO 99/52893 PCT/EP99/02313 -98- Table 154: A further preferred group of compounds of formula I corresponds to general R o formula Cl N 0 (1154), wherein the meanings of the corresponding X, R 3 0 substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1154 are disclosed.
Table 155: A further preferred group of compounds of formula I corresponds to general R 0 /H
H
formula Cl N Xl R30 X1 R3 O
I
-NCI-1 (1155), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 11ss are disclosed.
Table 156: A further preferred group of compounds of formula I corresponds to general Ri formula NC-- C H, formula NC N I (156), wherein the meanings of the corresponding N <N-CH Xl R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1156 are disclosed.
Table 157: A further preferred group of compounds of formula I corresponds to general RiO N ,CH, formula CH C- N H (1157), wherein the meanings of the corresponding N NC fX O
H
3 "o substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1157 are disclosed.
WO 99/52893 PCT/E P99/0231 3 -99- Table 158: A further preferred group of compounds of formula I corresponds to general R0 CH3 formula Br N 1 (11s5), wherein the meanings of the corresponding N N-CH 3 X, R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1158 are disclosed.
Table 159: A further preferred group of compounds of formula I corresponds to general R 0 _/formula NC- N H formula NC N N (1159), wherein the meanings of the corresponding N CH X, R, O substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula is59 are disclosed.
Table 160: A further preferred group of compounds of formula I corresponds to general R o N ,CH(CH)) 2 formula Cl N I (1160), wherein the meanings of the N /N-'CH(CH3)2 X, R, 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1160 are disclosed.
Table 161: A further preferred group of compounds of formula I corresponds to general R o formula Cl N I wherein the meanings of the corresponding N N-, X, R 3 substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1161 are disclosed.
WO 99/52893 PCT/EP99/02313 100- Table 162: A further preferred group of compounds of formula I corresponds to general formula Cl (1162), wherein the meanings of the corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1162 are disclosed.
Table 163: A further preferred group of compounds of formula I corresponds to general formula CI I -CH 3 (1163), wherein the meanings of the Na corresponding substituents Ri, X 1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1163 are disclosed.
Table 164: A further preferred group of compounds of formula I corresponds to general RO0 NCH3 formula CH N I (1164), wherein the meanings of the corresponding N CH X, R, 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 11 are disclosed.
Table 165: A further preferred group of compounds of formula I corresponds to general formula NC N I S (1165), wherein the meanings of the corresponding
N
x, R 3 O
X
1 Ro 3 0 substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1165 are disclosed.
WO 99/52893 PCT/EP99/02313 101 Table 166: A further preferred group of compounds of formula I corresponds to general
R
1
S
formula Cl N I S (166), wherein the meanings of the corresponding X, R, S substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1166 are disclosed.
Table 167: A further preferred group of compounds of formula I corresponds to general R 0 Nz formula CH3 N I S (1167), wherein the meanings of the N N \O X, R, 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1167 are disclosed.
Table 168: A further preferred group of compounds of formula I corresponds to general R1 o formula Cl- N N I wherein the meanings of the corresponding N N X,
R
3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1168 are disclosed.
Table 169: A further preferred group of compounds of formula I corresponds to general R O formula Cl N (1169), wherein the meanings of the corresponding N N I X, R 3
O
substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1169 are disclosed.
WO 99/52893 PCT/EP99/02313 -102- Table 170: A further preferred group of compounds of formula I corresponds to general R 1 formula C N I (1170), wherein the meanings of the
N
X R 3 0 corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1170 are disclosed.
Table 171: A further preferred group of compounds of formula I corresponds to general R 0 ua/ \N 0 formula NC -N I SN (1171), wherein the meanings of the N X, R 3 0 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1171 are disclosed.
Table 172: A further preferred group of compounds of formula I corresponds to general formula NC N O (1172), wherein the meanings of the corresponding N N X, R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1172 are disclosed.
Table 173: A further preferred group of compounds of formula I corresponds to general
R
1
CH
fol aC 3 N.N/CH3 formula CH 3 N -N O (1173), wherein the meanings of the S-v"o x1
R,
corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1173 are disclosed.
WO 99/52893 PCT/E P99/0231 3 -103- Table 174: A further preferred group of compounds of formula I corresponds to general formula CI I i'Y (1174), wherein the meanings of the 1 R 3 corresponding substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1174 are disclosed.
Table 175: A further preferred group of compounds of formula I corresponds to general
R,
formula N SN ,C R N xi R 3 (1175), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1175 are disclosed.
Table 176: A further preferred group of compounds of formula I corresponds to general
R,
formula NC- N NN C N N, X R 3 (1176), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1176 are disclosed.
Table 177: A further preferred group of compounds of formula I corresponds to general
R,
X 1 R3 (li7), wherein the meanings of the corresponding substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 11n are disclosed.
WO 99/52893 PCT/EP99/02313 -104- Table 178: A further preferred group of compounds of formula I corresponds to general R 0) formula Cl N Xi R3 (1178), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula li78 are disclosed.
Table 179: A further preferred group of compounds of formula I corresponds to general formula
O
RI N (1179), wherein the meanings of the corresponding C N S O X;
R
3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1179 are disclosed.
Table 180: A further preferred group of compounds of formula I corresponds to general formula
CI
(l11o), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 118o are disclosed.
Table 181: A further preferred group of compounds of formula I corresponds to general formula C .N (lia), wherein the meanings of the corresponding X N S x1 R WO 99/52893 PCT/EP99/02313 -105substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 118a are disclosed.
Table 182: A further preferred group of compounds of formula I corresponds to general formula (1182), wherein the meanings of the corresponding S- o X; R R 1 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1182 are disclosed.
Table 183: A further preferred group of compounds of formula I corresponds to general
R
1 formula Cl N N X N R,
S
xf R3 (l113), wherein the meanings of the corresponding substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1183 are disclosed.
Table 184: A further preferred group of compounds of formula I corresponds to general
R,
formula CI-/ 118), wherein the meanings of the corresponding X; R3 substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1184 are disclosed.
WO 99/52893 PCT/E P99/02313 -106- Table 185: A further preferred group of compounds of formula I corresponds to general
R,
formula NC N/ N (lies), wherein the meanings of the corresponding N SAs x, R3 substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 118s are disclosed.
Table 186: A further preferred group of compounds of formula I corresponds to general
R,
formula CH3_ N X R N1 (1186), wherein the meanings of the corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1186 are disclosed.
Table 187: A further preferred group of compounds of formula I corresponds to general
R,
formula CH3 N S
O
X
1
R
3 (1187), wherein the meanings of the corresponding substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula Ile7 are disclosed.
Table 188: A further preferred group of compounds of formula I corresponds to general formula C N N (lisa), wherein the meanings of the corresponding
R
3 WO 99/52893 PCT/EP99/02313 -107substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula lIs8 are disclosed.
Table 189: A further preferred group of compounds of formula I corresponds to general R O 1 NCH3 formula Cl N\ I (1189), wherein the meanings of the correspond N N CH Xi R 3 ing substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1189 are disclosed.
Table 190: A further preferred group of compounds of formula I corresponds to general
R
1 0 NON N CH 3 formula NC- \i C (19o), wherein the meanings of the corresponding N N CR 3
X
1 R 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 119o are disclosed.
Table 191: A further preferred group of compounds of formula I corresponds to general R0 formula CH C H formula CH 3 N N (1191), wherein the meanings of the correspon N N CH 3 X,
R
3 ding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1191 are disclosed.
Table 192: A further preferred group of compounds of formula I corresponds to general Ri1 NcHF formula Cl N (192), wherein the meanings of the corresponding N N CH-C X,
R
3 substituents R 1
X
1 and Ra are indicated in Table A, so that 423 specific compounds of formula 1192 are disclosed.
WO 99/52893 PCTIEP99/02313 -108- Table 193: A further preferred group of compounds of formula I corresponds to general R 0 /NfR 1 N
CHF
formula NC N (1193), wherein the meanings of the correspond N N "CH 3 Xl
R
3 substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1193 are disclosed.
Table 194: A further preferred group of compounds of formula I corresponds to general
R
1 NCHF2 formula Cl N\ H (114), wherein the meanings of the correspond N N CH 3 X,
R
3 substituents X 1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 114 are disclosed.
Table 195: A further preferred group of compounds of formula I corresponds to general R o
CHF
2 formula Cl -N (1195), wherein the meanings of the correspondi N N CH 3 Xi R 3 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1195 are disclosed.
ling ing ng Table 196: A further preferred group of compounds of formula I corresponds to general
R
1
O
>N CH3 formula Cl wherein the meanings of the corresponding N N CF, X,
R
substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1196 are disclosed.
WO 99/52893 PCT/EP99/02313 -109- Table 197: A further preferred group of compounds of formula I corresponds to general R O ,NCH(CH3)2 formula Cl N\ N CHF2 (1197), wherein the meanings of the N N CHF Xl
R
3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1197 are disclosed.
Table 198: A further preferred group of compounds of formula I corresponds to general N/CHF2 formula CF 3 N (198), wherein the meanings of the N N CH 3 X,
R
3 corresponding substituents Ri, X 1 and Ra are indicated in Table A, so that 423 specific compounds of formula 198g are disclosed.
Table 199: A further preferred group of compounds of formula I corresponds to general R 0 formula Cl IN (1199), wherein the meanings of the N N CH 3 Xi R3 corresponding substituents R 1 X, and R3 are indicated in Table A, so that 423 specific compounds of formula 1199 are disclosed.
Table 200: A further preferred group of compounds of formula I corresponds to general R0
N
formula C. /N-N formula C (1200), wherein the meanings of the N N CH3 X, R3 corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1200 are disclosed.
WO 99/52893 PCT/E P99/02313 -110- Table 201: A further preferred group of compounds of formula I corresponds to general Ri o formula Cl N (1201), wherein the meanings of the N N CH 3 X,
R
3 corresponding substituents R 1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1201 are disclosed.
Table 202: A further preferred group of compounds of formula I corresponds to general R, o
N
formula CH 3 N IN O (1202), wherein the meanings of the N N CH 3 X,
R
3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1202 are disclosed.
Table 203: A further preferred group of compounds of formula I corresponds to general R 0
N-,CHF
2 formula CFO 3 0 NN (1203), wherein the meanings of the N N CcH 3 X,
R
3 corresponding substituents R 1 X, and Rs are indicated in Table A, so that 423 specific compounds of formula 12o3 are disclosed.
Table 204: A further preferred group of compounds of formula I corresponds to general
R
1 formula Cl (1204), wherein the meanings of the corresponding -N N X,
R
3 substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1204 are disclosed.
_I
_UI__L~
0 EP 0099023 13 o20030452/A -111 Table 205: A further preferred group of compounds of formula I corresponds to general R 0 )WN formula CI N (1205), wherein the meanings of the corresponding X, N Xi R3 substituents
R
1
X
1 and R 3 are indicated in Table A, so that 423 specific compounds of formula 1205 are disclosed.
Table 206: A further preferred group of compounds of formula I corresponds to general R
CH,
R, O3 formula Br N 1 2 6 wherein the meanings of the corresponding N BN -CHF 2
X
1
R
3 substituents
R
1 X and R 3 are indicated in Table A, so that 423 specific compounds of formula 1206 are disclosed.
Table 207: A further preferred group of compounds of formula I corresponds to general R 1 formula NC Ny ;3 (1207), wherein the meanings of the corresponding N
N
X, R3 substituents
R
1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1207 are disclosed.
Table 208: A further preferred group of compounds of formula I corresponds to general Ro formula Cl N (1208), wherein the meanings of the corresponding N
N
X
1 R, substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1208 are disclosed.
T^ AMENDED SHEET WO 99/52893 PCT/EP99/02313 -112- Table 209: A further preferred group of compounds of formula I corresponds to general R 10 CH 3
F
formula O N F (1209), wherein the meanings of the corresponding CH 3 N N F X; R, substituents RI, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1209 are disclosed.
Table 210: A further preferred group of compounds of formula I corresponds to general R 1 0
CH
3
F
formula 0 N\ F (1210), wherein the meanings of the N-N N F Xf
R,
corresponding substituents Ri, X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1210 are disclosed.
Table 211: A further preferred group of compounds of formula I corresponds to general R 1 0i formula (CH 3) CHO -N (1211), wherein the meanings of the N N
F
x R 3 o corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 12, are disclosed.
Table 212: A further preferred group of compounds of formula I corresponds to general R 0 CH 3 F
F
formula F N F (1212), wherein the meanings of the F N N F
X
1 R 3 corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1212 are disclosed.
WO 99/52893 PCT/EP99/02313 -113- Table 213: A further preferred group of compounds of formula I corresponds to general
RO
formula (CH 3) C N (1213), wherein the meanings of the N
N>
X, R3 O corresponding substituents X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1213 are disclosed.
Table 214: A further preferred group of compounds of formula I corresponds to general R 0
CH,
F
formula (CH 3) 3 C N F (1214), wherein the meanings of the N N
F
X; R corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1214 are disclosed.
Table 215: A further preferred group of compounds of formula I corresponds to general R 0
F
formula Cl N F (1215), wherein the meanings of the N N F X 1 R 3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1215 are disclosed.
Table 216: A further preferred group of compounds of formula I corresponds to general formula F N (1216), wherein the meanings of the corresponding F N X, R 3 0 substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1216 are disclosed.
WO 99/52893 PCT/EP99/02313 -114- Table 217: A further preferred group of compounds of formula I corresponds to general
R
1 0 N CHF formula IO N 3 (1217), wherein the meanings of the N N CH 3 X, R, corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1217 are disclosed.
Table 218: A further preferred group of compounds of formula I corresponds to general R 1 0
CH
3
F
formula 0 N F (1218) wherein the meanings of the N N F F X 1
R
3 corresponding substituents R 1 X, and R 3 are indicated in Table A, so that 423 specific compounds of formula 1218 are disclosed.
Table 219: A preferred group of compounds of formula I corresponds to general formula R,0 F
F
F N H (1219), wherein the meanings of the corresponding F -N F X f R 3 O CH 3 substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1219 are disclosed.
Table 220: A preferred group of compounds of formula I corresponds to general formula
R
1 0 Ro
F
0 N F (1220), wherein the meanings of the N N N\ F N X R, 30 CH corresponding substituents R 1 X, and Ra are indicated in Table A, so that 423 specific compounds of formula 1220 are disclosed.
WO 99/52893 PCT/EP99/02313 -115- Table A Comp. No. R, X R 3 .001 H 0 CH 3 .002 F 0 CH 3 .003 CI 0 CH 3 .004 F 0 CH 2
CH
3 .005 Cl 0 CH 2
CH
3 .006 H 0 CH 2
CH
3 .007 F 0 CH 2
CH
2
CH
3 .008 CI 0 CH 2
CH
2
CH
3 .009 H 0 CH 2
CH
2
CH
3 .010 F 0 CH 2
CH
2
CH
2
CH
3 .011 CI 0 CH 2
CH
2
CH
2
CH
3 .012 F 0 CH 2
CH
2
CH
2
CH
2
CH
3 .013 CI 0 CH 2
CH
2
CH
2
CH
2
CH
3 .014 F 0 CH 2
CH
2
CH
2
CH
2
CH
2
CH
3 .015 F 0 CH 2
CH
2
CH(CH
3 2 .016 CI 0 CH 2
CH
2
CH(CH
3 2 .017 H 0 CH 2
CH
2
CH(CH
3 2 .018 F 0 CH 2
CH(CH
3
)CH
2
CH
3 .019 CI 0 CH 2
CH(CH
3
)CH
2
CH
3 .020 H 0 CH 2
CH(CH
3
)CH
2
CH
3 .021 F 0 CH 2
CH(CH
3
)CH
2
CH
2
CH
3 .022 F 0 CH 2
CH
2
CH(CH
3
)CH
2
CH
3 .023 F 0 CH 2
CH
2
CH
2
CH(CH
3 2 .024 F 0 CH(CH 3
)CH
2
CH
2
CH
2
CH
3 .025 CI 0 CH(CH 3
)CH
2
CH
2
CH
2
CH
3 .026 H 0 CH(CH 3
)CH
2
CH
2
CH
2
CH
3 .027 F 0 CH 2
C(CH
3 3 .028 CI 0 CH 2
C(CH
3 3 .029 H 0 CH 2
CH(CH
3 2 .030 CI 0 CH 2
CH(CH
3 2 .031 F 0 CH 2
CH(CH
3 2 .032 F 0 CH 2
C(CH
3 2
CH
2
CH
3 .033 CI 0 CH 2
C(CH
3 2
CH
2
CH
3 .034 H 0 CH 2
C(CH
3 2
CH
2
CH
3 WO 99/52893PC/9/033 PCT/EP99/02313 -116- Comp. No. R, X R 3 .035 F 0 CH 2
CH
2
C(CH
3 3 .036 CI 0 CH 2
CH
2
C(CH
3 3 .037 F 0 CH 2
CH
2
CHCH
2 .038 F 0 CH 2
CH
2
CH
2
CH
3 .039 F 0 CH(CH 3 2 .040 CI 0 CH(CH 3 2 .041 H 0 CH(CH 3 2 .042 F 0 CH 2
CF
3 .043 CI 0 CH 2
CF
3 .044 H 0 CH 2
CF
3 .045 F 0 CH 2
CCI
3 .046 F 0 CH 2
CH
2
CF
3 .047 F 0 CH 2
CH
2
CH(OH)CH
3 .048 F 0 CH 2 CH(0H)CH 2
CH
3 .049 CI 0 CH 2 CH(0H)CH 2
CH
3 .050 F 0 CH 2
CH(OH)CH
3 .051 H 0 CH 2
CH
2
CHCICH
3 .052 CI 0 CH 2
CH
2
CHCICH
3 .053 F 0 CH 2
CH
2
CHCICH
3 .054 F 0 CH 2
CH
2
CHFCH
3 .055 F 0 CH 2
CHFCH
2
CH
3 .056 CI 0 CH 2
CHFCH
2
CH
3 .057 H 0 CH 2
CHFCH
2
CH
3 .058 F 0 CH 2
CHCICH
2
CH
3 .059 F 0 CH 2
CH
2
F
.060 CI 0 CH 2
CH
2
F
.061 F 0 CH 2
CHF
2 .062 H 0 CH 2
CHCH
2 .063 CI 0 CH 2
CHCH
2 .064 F 0 CH 2
CHCH
2 .065 F 0 CH 2
CH(CH
3
)CH
2 .066 F 0 CH 2
CHCH(CH
3 .067 CI 0 CH 2
CH
2 0H .068 F 0 CH 2
CH
2 0H .069 F 0 CH 2
CHCHCI
WO 99/52893 PTE9/21 PCT/EP99/02313 117- Comp. No. R, X R 3 .070 CI 0 CH 2
CHCHCI
.071 F 0 CH 2
OCH
2
C
6
H
.072 H 0 CH 2 00H .073 CI 0 CH 2
CCH
.074 F 0 CH 2
CCH
.075 F 0 CH 2
CH
2
CCH
.076 CI 0 CH 2
CH
2
C
6
H
.077 F 0 CH 2
CH
2
C
6
H
.078 F 0 CH 2
CH
2
CH
2
C
6
H
.079 F 0 CH 2
CH
2
CH(CH
3
)C
6
H
.080 F 0 CH 2
CH
2
CH
2
CH
2 (p-F-C 6
H
4 .081 H 0 CH 2
C
6 .082 CI 0 CH 2
C
6
H
.083 F 0 CH 2
C
6
H
.084 F 0 CH 2 (o-F-C 6
H
4 .085 H 0 CH 2
(P-C-C
6
H
4 .086 F 0 CH 2
(M-CF
3
-C
6
H
5 .087 H 0 CH 2
CN
.088 CI 0 CH 2
CN
.089 F 0 CH 2
CN
.090 F 0 CH 2
CH
2
CN
.091 F 0 cyclopropyl .092 F 0 cyclopentyl .093 F 0 CH 2 -cyclopentyl .094 F 0 CH 2 -CYClopropyl .095 F 0 CH 2
CH
2
CI
.096 F 0 CH 2
CHC
2 .097 H 0 CH 2 00H 3 .098 CI 0 CH 2
OCH
3 .099 F 0 CH 2 0CH 3 .100 F 0 CH 2
CH
2 00H 3 .101 F 0 CH 2
CH
2 0CH 2
CH
3 .102 F 0 CH 2
CH(CH
3 )0CH 3 .103 H 0 CH 2
CH
2
OCH
2
CH
2 0CH 3 .104 1CI 0 CH 2
CH
2 0CH 2
CH
2 0CH 3 WO 99/52893 PCT/EP99/02313 Comp. No. R, ,R .105 F 0 CH 2
CH
2
OCH
2
CH
2
OCH
3 .106 H 0 CH 2
SCH
3 .107 Cl 0 CH 2
SCH
3 .108 F 0 CH 2
SCH
3 .109 H 0 CH 2 S(0)CH 3 .110 Ci 0 CH 2 S(0)CH 3 .111 F 0 CH 2 S(0)CH 3 .112 H 0 CH 2 S(0) 2
CH
3 .113 CI 0 CH 2 S(0) 2
CH
3 .114 F 0 CH 2
S(O)
2
CH
3 .115 F 0 CH 2
SCH
2
CH
3 .116 F 0 CH 2
CH
2
SCH
3 .117 F 0 CH 2
CH
2
SCH
2
CH
3 .118 CI 0 CH 2
CH
2
SCH
2
CH
3 .119 H 0 CH 2
CH
2
SCH
2
CH
3 .120 CI 0 CH 2
CH
2
SCH
3 .121 H 0 CH 2
CH
2
SCH
3 .122 F 0 CH 2
CH
2 S(0)CH 3 .123 F 0 CH 2
CH
2 S(0) 2
CH
3 .124 CI 0 CH 2
CH
2 S(0)CH 3 .125 CI 0 CH 2
CH
2 S(0) 2
CH
3 .126 F 0 CH 2
CH
2 S(0)CH 2
CH
3 .127 CI 0 CH 2
CH
2 S(0)CH 2
CH
3 .128 H 0 CH 2
CH
2 S(0)CH 2
CH
3 .129 F 0 CH 2
CH
2 S(0) 2
CH
2
CH
3 .130 CI 0 CH 2
CH
2 S(0) 2
CH
2
CH
3 .131 H 0 CH 2
CH
2 S(0) 2
CH
2
CH
3 .132 F 0 CH 2
CH(CH
3
)SCH
3 .133 H 0 CH 2 CO0H .134 CI 0 CH 2
COOH
.135 F 0 CH 2
COOH
.136 F 0 CH 2
COOCH
3 .137 H 0 CH 2 CO0CH 2
CH
3 .138 CI 0 CH 2 000CH 2
CH
3 .139 1F 0 CH 2 CO0CH 2
CH
3 WO 99/52893 PCT/EP99/02313 -119- Comp. No. R, X R 3 .140 F 0 CH 2
COOC(CH
3 3 .141 F 0 CH 2
COOCH
2
CHCH
2 .142 F 0 CH 2 C00CH 2
CCH
.143 F 0 CH 2 C00CH 2
C
6
H
.144 H 0 CH 2
CHO
.145 CI 0 CH 2
CHO
.146 F 0 CH 2
CHO
.147 H 0 CH 2 C(0)CH 3 .148 CI 0 CH 2 C(0)0H 3 .149 F 0 CH 2 C(0)CH 3 .150 F 0 CH 2 C0SCH 2
CH
3 .151 H 0 CH 2 00SCH(CH 3 2 .152 CI 0 CH 2 C0SCH(CH 3 2 .153 F 0 CH 2
COSCH(CH
3 2 .154 F 0 CH 2 00SCH 2
C
6
H
.155 F 0 CH 2 C0NH 2 .156 F 0 CH 2 00N(CH 3 2 .157 CI 0 CH 2 00N(CH 3 2 .158 F 0 CH 2
CON(CH
2
CH
3 2 .159 CI 0 CH 2 C0N(CH 2
CH
3 2 .160 H 0 CH 2
CON(CH
2
CH
3 2 .161 F 0 CH 2
OCH
2
C
6
H
.162 CI 0 CH 2 C0NHCH 2
CCH
.163 F 0 CH 2
CONHCH
2
CCH
.164 CI 0 CH 2
CH
2 C0OH .165 F 0 CH 2
CH
2 CO0H .166 F 0 CH 2
CH
2
COOCH
2
CH
3 .167 H 0 CH 2
CH
2
CN
.168 CI 0 CH 2
CH
2
CN
.169 F 0 CH 2
CH
2
CN
.170 F 0 CH 2
CH(CH
3
)CN
.171 CI 0 CH(CH 3
)CH
2
CN
.172 CI 0 CH 2
CH
2 CH0 .173 F 0 CH 2
CH
2 CH0 .174 F 0 CH 2
CH
2 C(0)CH 3 WO 99/52893 PCT/EP99/02313 120- Comp. No. R, XR 3 .175 CI 0 CH 2
CH
2 C(0)CH 3 .176 F 0 CH 2
COCH
2
CH
3 .177 CI 0 CH 2
COCH
2
CH
3 .178 H 0 CH 2
COCH
2
CH
3 .179 F 0 CH 2 00CH 2
CH
2
CH
3 .180 F 0 CH 2
CH
2 C0CH 2
CH
3 .181 F 0 CH 2
CH
2
COCH
2
CF
3 .182 F 0 CH 2
CHCICOCH
2
CH
3 .183 F 0 CH 2
CH
2 00CHCICH 3 .184 F 0 CH 2
CH(CH
3
)COOCH
3 .185 F 0 CH 2
CH
2
CH
2 C00CH 3 .186 F 0 CH 2
CH
2
CH
2 C0SCH 2
CH
3 .187 F 0 CH 2
CH
2
CH
2
CON(CH
3 2 .188 F 0 CH 2
CH
2
CH(CH
3 )CO0CH 2 CH3 .189 H 0 CH 2 CH(OH)C0OH .190 CI 0 CH 2 CH(0H)C00H .191 F 0 CH 2 CH(0H)COOH .192 CI 0 CH 2 CH(CI)C00H .193 F 0 CH 2 CH(CI)C0OH .194 CI 0 CH 2 CH(CI)C00CH 2
CH
3 .195 F 0 CH 2 CH(CI)C000H 2
CH
3 .196 F 0 CH 2 CH(CI)C0OH .197 F 0 CH 2
C(CH
3
)(CI)COOH
.198 F 0 CH 2
CH(CI)COOCH
2
CHCH
2 .199 F 0 CH 2
CH(CI)COOCH
2
CCH
.200 F 0 CH 2 CH(CI)C00CH 2
C
6
H
.201 F 0 CH 2 CH(CI)C(0)SCH(CH 3 2 .202 F 0 CH 2 CH(CI)C(0)NH(CH 2
CCH)
.203 F 0 CH 2
CH(CH
3 )C(0)N(CH 3
)(CH
2
CHCH
2 .204 F 0 CH 2 CH(Br)C00C(CH 3 3 .205 F 0 CH 2 CH(Br)C0OCH 2
CHCH
2 .206 F 0 CH 2 C000H 2
CH
2
CI
.207 F 0 CH 2 CO0CH 2
CF
3 .208 H 0 CH< WO 99/52893PC/P9/23 PCT/EP99/02313 121 Comp. No. R, X, R 3 .209 H 0HY1 .210 CI 0 CH< .211 F 0 C H2-<l .212 F 0 C~ .213 F 0 S(O) 2
CH
3 .214 F 0 S(O) 2
CH
2
CH
3 .215 CI 0 S(O) 2
CF
3 .216 Ci 0 S(O) 2
CH
2
CH
3 .217 F 0 S(O) 2
CH(CH
3 2 .218 H 0 C(O)CH 3 .219 CI 0 C(O)CH 3 .220 F 0 C(O)CH 3 .221 F 0 C(0)CF 3 .222 F 0 C(0)CH 2
CH
3 .223 CI 0 OH .224 F 0 OH .225 H 0 OCH 3 .226 CI 0 OCH 3 .227 F 0 OCH 3 .228 H 0 OCH 2
CH
3 .229 CI 0 OCH 2
CH
3 .230 F 0 OCH 2
CH
3 .231 F 0 OCH 2
CH(CH
3 2 .232 F 0 OCF 3 .233 F 0 OCHF 2 .234 F 0 OCH 2
CHCH
2 .235 F 0 OCH 2
C(CH
3
)CH
2 .236 F 0 OCH 2
CHCHCI
.237 CI 0 OCH 2
OCH
3 .238 F 0 OCH 2
OCH
3 .239 F 0 OCH 2
SCH
3 WO 99/52893 PCT/E P99/02313 122 Comp. No. R, X R 3 .240 F 0 OCH 2
CCH
.241 F 0 OCH 2 000H .242 F 0 OCH 2 CO0CH 3 .243 F 0 OCH 2 CO0CH 2
CH
3 .244 F 0 OCH 2
COOCH(CH
3 2 .245 CI 0 0CH(CH 3
)COOH
.246 F 0 0CH(CH 3 )CO0H .247 F 0 OCH(CH 3 )CO0CH 2
CH
3 .248 F 0 OCH(CH 3 )C00CH 2
CCH
.249 F 0 0CH(CH 3 )CO0CH 2
CHCH
2 .250 F 0 0CH 2 00SCH 2
CH
3 .251 F 0 OCH 2 C0SCH(CH 3 2 .252 F 0 0CH 2 C0SCH 2
C
6
H
.253 F 0 0CH 2 C0NH 2 .254 F 0 0CH 2 00N(CH 3 2 .255 CI 0 OCH 2 C0NHCH 2
CCH
.256 F 0 OCH 2
CONHCH
2
CCH
.257 F 0 OCH 2
C
6
H
.258 F 0 OCH 2
(P-CH
3
O-C
6
H
4 .259 F 0 OCH 2 (o-F-C 6
H
4 .260 CI 0 OCH 2
(M-CF
3
-C
6
H
4 .261 F 0 0CH 2
CH
2
C
6
H
.262 H 0 OCH 2
CN
.263 F 0 OCH 2
CN
.264 F 0 0CH 2
CH
2
CI
.265 cI 0 OCH 2
CH
2
OH
.266 F 0 0CH 2
CH
2
OH
.267 H 0 0CH 2
CH
2
CN
.268 CI 0 OCH 2
CH
2
CN
.269 F 0 OCH 2
CH
2
CN
.270 CI 0 OCH 2
CH(OCH
3
)(CH
3 .271 F 0 0CH 2
CH(OCH
3
)(CH
3 .272 H 0 OC(0)CH 3 .273 cI 0 OC(0)CH 3 .274 F 0 OC(0)CH 3 WO 99/52893 PCT/EP99/023 13 123- Comp. No. R, ,R .275 H s CH 3 .276 CI S CH 3 .277 F S CH 3 .278 H S CH 2
CH
3 .279 CI S CH 2
CH
3 .280 F S CH 2
CH
3 .281 F S CH 2
CH
2
CH
3 .282 F S CH 2
CH(CH
3 2 .283 F S CH 2
CH
2
CF
3 .284 F S CH(CH 3 2 .285 F S CH 2
CH(CH
3 2 .286 F S CH 2
CH(CI)CH
3 .287 CI S CH 2
CHCH
2 .288 F S CH 2
CHCH
2 .289 F S CH 2
C(CH
3
)CH
2 .290 H S CH 2
CCH
.291 CI S CH 2
CCH
.292 F S CH 2
CCH
.293 F S CH 2
CH
2
CCH
.294 F S CH(CH 3
)CCH
.295 H S CH 2
CH
2
OH
.296 CI S CH 2
CH
2
OH
.297 F S CH 2
CH
2
OH
.298 F S CH 2
CH(OH)CH
3 .299 H S CH 2
C
6 .300 CI S CH 2
C
6 .301 F S CH 2
C
6 .302 CI S CH 2 (o-F-C 6
H
4 .303 F S CH 2 (o-F-C 6
H
4 .304 F S CH 2
(M-CF
3
-C
6
H
4 .305 F S CH 2
(P-CH
3
-C
6
H
4 .306 F S CH 2 (2,4-di-F-C 6
H
3 .307 F S CH 2
CH
2
CH(CH
3
)C
6
H
.308 F S CH 2
CH
2
CH
2
CH
2
(P-F-C
6
H
4 .309 I cls CH 2
CN
WO 99/52893 PTE9/21 PCT/EP99/02313 -124- Comp. No. R, ,R .310 F S CH 2
CN
.311 F S cyclopropyl .312 CI S CH 2 -CYClopropyl .313 F S CH 2 -cyclopropyl .314 F S CH 2
CI
.315 H S CH 2
OCH
3 .316 CI S CH 2 00H 3 .317 F S CH 2
OCH
3 .318 F S CH 2
OCH
2
CHCH
2 .319 F S CH 2
CH
2
OCH
3 .320 F S CH 2
CH(OCH
3
)CH
3 .321 F S CH 2
CH(OCH
2
CCH)CH
3 .322 H S CH 2
CH
2
OCH
2
CH
2
OCH
3 .323 CI S CH 2
CH
2
OCH
2
CH
2
OCH
3 .324 F S CH 2
CH
2
QCH
2
CH
2
OCH
3 .325 H S CH 2
SCH
3 .326 CI S CH 2
SCH
3 .327 F S CH 2
SCH
3 .328 F S CH 2
SCH
2
CHCH
2 .329 F S CH 2
SCH
2
CCH
.330 F S CH 2
CH
2
SCH
3 .331 F S CH 2
CH
2
S(O)CH
3 .332 F S CH 2
CH
2
S(O)
2
CH
3 .333 F S CH 2
COOH
.334 F S CH 2 000CH 3 .335 F S CH 2
COOCH
2
CH
3 .336 F S CH 2
COOC(CH
3 3 .337 F S CH 2
COOCH
2
C
6
H
.338 F S CH 2
COOCH
2
(P-C-C
6
H
4 .339 F S CH 2
C(O)SCH
3 .340 F S CH 2
C(O)SCH(CH
3 2 .341 F S CH 2
C(O)SCH
2
C
6
H
.342 F S CH 2
C(O)NH
2 .343 F S CH 2
C(O)NH(CH
3 .344 I clS CH 2
C(O)NH(CH
2
CCH-)
WO 99/52893 C/P9031 PCT/EP99/02313 125- Comp. No. R, XR 3 .345 F s CH 2
C(O)NH(CH
2
CCH)
.346 F s CH 2
C(O)N(CH
2
CH
3 2 .347 F S CH 2
CHO
.348 F S CH 2
C(Q)CH
3 .349 H S CH 2
CH
2 000H .350 CI s CH 2
CH
2
COOH
.351 F S CH 2
CH
2
COOH
.352 F S CH 2
CH
2
COOCH
3 .353 F S CH 2
CH
2 000CH 2
C
6
H
.354 ci s CH 2
CH
2
C(O)SCH
2
CH
3 .355 F S CH 2
CH
2
C(O)SCH
2
CH
3 .356 F S CH 2
CH(OH)COOH
.357 F S CH 2
CH(CI)COOH
.358 CI S CH 2
CH(CI)COOCH
2
CH
3 .359 F s CH 2
CH(CI)COOCH
2
CH
3 .360 F S CH 2
CH(CI)COOH
.361 F S CH 2
C(CH
3
)(CI)COOH
.362 F S CH 2
CH(CI)COOCH
2
CHCH
2 .363 CI S CH 2
CH(CI)COOCH
2
CCH
.364 F S CH 2
CH(CI)COOCH
2
CCH
.365 F S CH 2
CH(CI)COOCH
2
C
6
H
.366 F S CH 2 CH(Br)COOH .367 F S CH 2
CH(CI)C(O)SCH(CH
3 2 .368 F S CH 2
CH(CI)C(O)NH(CH
2
CCH)
.369 F S CH 2
CH(CH
3
)C(O)N(CH
3
)(CH
2
CHCH
2 .370 F S CH 2
CH
2
C(O)NH(CH
2 00H) .371 H S CH-KI .372 CI S \2<l% .373 F S CH-<l .374 CI S C H-< .375 F CHs WO 99/52893PC/P9033 PCT/EP99/02313 -126- Comp. No. R, X R 3 .376 F S OH .377 H S OCH 3 .378 CI S OCH 3 .379 F S OCH 3 .380 F S OCH 2
CH
3 .381 CI S OCH 2
CH(CH
3 2 .382 F S OCH 2
CH(CH
3 2 .383 F S OCH(CH 3 2 .384 F S OCF 3 .385 H S OCH 2 00H 3 .386 CI S OCH 2 0CH 3 .387 F S OCH 2 00H 3 .388 F S OCH 2
SCH
3 .389 CI S OCH 2
CHCH
2 .390 F S OCH 2
CHCH
2 .391 CI S OCH 2
CCH
.392 F S OCH 2 00H .393 F S OCH(CH 3
)CHCH
2 .394 F S OCH(CH 3
)CCH
.395 F S OCH 2
CHCH(CI)
.396 F S OCH 2
COOH
.397 F S OCH 2
COOCH
2
CH
3 .398 F S OCH(CH 3
)COOH
.399 F S OCH(CH 3
)COOCH
2
CCH
.400 F S OCH 2
C(O)NH
2 .401 F S OCH 2
C(O)NH(CH
3 .402 F S OCH 2
C(O)NH(CH
2
CCH)
.403 F S OCH 2
C(O)SCH
3 .404 F S OCH 2
C(O)SCH
2
CH
3 .405 F S OCH 2
C(O)SCH(CH
3 2 .406 ci s OCH 2
C(O)SCH
2
C
6
H
.407 F S OCH(CH 3
)C(O)SCH
2 C6H .408 F s OCH 2
CH
2
OH
.409 F s OCH 2
CH(CH
3
)OH
.410 1F S OCH 2
CH
2
CI
WO 99/52893 PCT/E P99/02313 127- Comp. No. R, X R 3 .411 CI S OCH 2
CH
2
CN
.412 F S OCH 2
CH
2
CN
.413 Cl S OCH 2
CH
2
CF
3 .414 F S OCH 2
CH
2
CF
3 .415 F S OCH 2
CH(OH)(C
6
H
5 .416 F 0 CH 2 00CH 3 .417 F 0 CH 2
CONHCH
2
CH=CH
2 .418 Ci 0 CH 2
CONHCH
2
CH=CH
2 .419 CI S CH 2 00NHCH 2
CH
3 .420 CI 0 CH 2
CONHCH
2
CH
3 .421 F 0 CH 2
CONHCH
2
CH
3 .422 F 0 CH 2
CONHCH
3 .423 Cl 0 CH 2
CONHCH
3 Table B: Prepared compounds from the preceding Tables with physico-chemical data.
The figure before the point indicates the number of the Table, e.g. 1.002 indicates in Table 1 compound No. 002 of Table A.
Comp. No. physical data 1.002 m.p. 159-160 0
C
1.007 m.p. 123-1 2500 1.064 m.p. 115-116 0
C
1.071 nD(30 0 C) 1.5431 1.074 m.p. 218-2200C 1.139 nD(30'C) 1.5131 34.074 'H-NMR (CDC1 3 8,14 ppm I1H); 7,72 ppm 1 H); ppm 1 4,90 ppm 2H); 2,21 ppm 1 H) Examples of specific formulations for compounds of formula 1, such as emulsifiable concentrates, solutions, wettable powders, coated granules, extruder granules, dusts and suspension concentrates, are described on pages 9 to 13 of WO 97/34485.
Biological Examples Example B31: Herbicidal action poor to emergence of the Dlants (Dre-emergence action) WO 99/52893 PCT/EP99/02313 -128- Monocotyledonous and dicotyledonous test plants are sown in standard soil in plastics pots.
Immediately after sowing, the test compounds, in the form of an aqueous suspension (prepared from a 25 wettable powder (Example F3, as described, for example, in WO 97/34485), or in the form of an emulsion (prepared from a 25 emulsifiable concentrate (Example F1, as described, for example, in WO 97/34485), are applied by spraying in a concentration corresponding to 2000 g of active ingredient/ha (500 litres water/ha). The test plants are then grown in a greenhouse under optimum conditions. After a test duration of 3 weeks, the test is evaluated in accordance with a scale of nine ratings (1 total damage, 9 no action). Ratings of from 1 to 4 (especially from 1 to 3) indicate good to very good herbicidal action. In this test the compounds of formula I exhibit strong herbicidal action.
Test plants: Lolium, Setaria, Sinapis, Solanum, Ipomoea Examples of the good herbicidal activity of the compounds of formula I are given in Table B1.
Table B1: Pre-emergence action: Test plant: Lolium Setaria Sinapis Solanum Ipomoea conc.
[g a.i./ha] Comp. No.
1.002 1 1 1 1 2 2000 1.007 3 1 1 1 1 2000 1.064 3 1 1 1 1 2000 1.071 6 1 1 1 3 2000 1.074 1 1 1 1 1 2000 1.139 1 1 1 1 1 2000 The same results are obtained when compounds of formula I are formulated in accordance with Examples F2 and F4 to F8 according to WO 97/34485.
Example B2: Post-emergence herbicidal action In a greenhouse, monocotyledonous and dicotyledonous test plants are grown in standard soil in plastics pots and at the 4- to 6-leaf stage are sprayed with an aqueous suspension of the test compounds of formula I, prepared from a 25 wettable powder (Example F3, b) according to WO 97/34485), or with an emulsion of the test compounds of formula I, prepared from a 25 emulsifiable concentrate (Example Fl, c) according to WO 99/52893 PCT/EP99/02313 -129- WO 97/34485), in a concentration corresponding to 2000 g of active ingredient/ha (500 litres water/ha). The test plants are then grown on in a greenhouse under optimum conditions. After a test duration of about 18 days, the test is evaluated in accordance with a scale of nine ratings (1 total damage, 9 no action). Ratings of from 1 to 4 (especially from 1 to 3) indicate good to very good herbicidal action.
Test plants: Lolium, Setaria, Sinapis, Solanum, Ipomoea In this test too, the compounds of formula I according to the invention exhibit strong herbicidal action.
Examples of the good herbicidal activity of the compounds of formula I are given in Table B2.
Table B2: Post-emergence action: Test plant: Lolium Setaria Sinapis Solanum Ipomoea conc.
[g a.i./ha] Comp. No.
1.002 1 1 1 1 1 2000 1.007 2 2 1 1 1 2000 1.064 4 4 3 1 1 2000 1.071 2 2 1 1 3 2000 1.074 1 1 1 1 1 2000 1.139 1 1 1 1 1 2000 The same results are obtained when compounds of formula I are formulated in accordance with Examples F2 and F4 to F8 according to WO 97/34485.
The compounds of formula I according to the invention can also be used for weed control in admixture with known herbicides as co-herbicides, for example in the form of readyprepared formulations or in the form of a 'tank-mix'. Suitable mixing partners for the compounds of formula I include, for example, the following co-herbicides: compound of formula I acetochlor, compound of formula I acifluorfen, compound of formula I aclonifen, compound of formula I alachlor, compound of formula I ametryn, compound of formula I aminotriazole, compound of formula I amidosulfuron, compound of formula I asulam, compound of formula I atrazine, compound of formula I BAY FOE 5043, compound of formula I benazolin, compound of formula I bensulfuron, compound of WO 99/52893 PCTIEP99/02313 -130formula I bentazone, compound of formula I bifenox, compound of formula I bispyribac-sodium, compound of formula I bialaphos, compound of formula I bromacil, compound of formula I bromoxynil, compound of formula I bromophenoxim, compound of formula I butachlor, compound of formula I butylate, compound of formula I cafenstrole, compound of formula I carbetamide, compound of formula I chloridazone, compound of formula I chlorimuron-ethyl, compound of formula I chlorbromuron, compound of formula I chlorsulfuron, compound of formula I chlortoluron, compound of formula I cinosulfuron, compound of formula I clethodim, compound of formula I clodinafop, compound of formula I clomazone, compound of formula I clopyralid, compound of formula I cloransulam, compound of formula I cyanazine, compound of formula I cyhalofop, compound of formula I dalapon, compound of formula I 2,4-D, compound of formula I 2,4-DB, compound of formula I desmetryn, compound of formula I desmedipham, compound of formula I dicamba, compound of formula I diclofop, compound of formula I difenzoquat metilsulfate, compound of formula I diflufenican, compound of formula I dimefuron, compound of formula I dimepiperate, compound of formula I dimethachlor, compound of formula I dimethametryn, compound of formula I dimethenamid, compound of formula I S-dimethenamid, compound of formula I dinitramine, compound of formula I dinoterb, compound of formula I dipropetryn, compound of formula I diuron, compound of formula I diquat, compound of formula I DSMA, compound of formula I EPTC, compound of formula I esprocarb, compound of formula I ethalfluralin, compound of formula I ethametsulfuron, compound of formula I ethephon, compound of formula I ethofumesate, compound of formula I ethoxysulfuron, compound of formula I fenclorim, compound of formula I flamprop, compound of formula I fluazasulfuron, compound of formula I fluazifop, compound of formula I flumetralin, compound of formula I flumetsulam, compound of formula I fluometuron, compound of formula I flurochloridone, compound of formula I fluoxaprop, compound of formula I fluroxypyr, compound of formula I fluthiacet-methyl, compound of formula I fluxofenim, compound of formula I fomesafen, compound of formula I glufosinate, compound of formula I glyphosate, compound of formula I halosulfuron, compound of formula I haloxyfop, compound of formula I hexazinone, compound of formula I imazamethabenz, compound of formula I imazapyr, compound of formula I imazaquin, compound of formula I imazethapyr, compound of formula I imazosulfuron, compound of formula I ioxynil, compound of formula I isoproturon, compound of formula I isoxaben, compound of formula I isoxaflutole, compound of formula I karbutylate, compound of formula I lactofen, compound of formula I lenacil, compound of formula I linuron, compound of formula I MCPP, compound of formula I metamitron, WO 99/52893 PCT/EP99/02313 -131 compound of formula I metazachlor, compound of formula I methabenzthiazuron, compound of formula I methazole, compound of formula I metobromuron, compound of formula I metolachlor, compound of formula I S-metolachlor, compound of formula I metosulam, compound of formula I metribuzin, compound of formula I metsulfuronmethyl, compound of formula I molinate, compound of formula I MCPA, compound of formula I MSMA, compound of formula I napropamide, compound of formula I NDA- 402989, compound of formula I nefenacet, compound of formula I nicosulfuron, compound of formula I norflurazon, compound of formula I oryzalin, compound of formula I oxadiazon, compound of formula I oxasulfuron, compound of formula I oxyfluorfen, compound of formula I paraquat, compound of formula I pendimethalin, compound of formula I phenmedipham, compound of formula I phenoxaprop-P-ethyl compound of formula I picloram, compound of formula I pretilachlor, compound of formula I primisulfuron, compound of formula I prometon, compound of formula I prometryn, compound of formula I propachlor, compound of formula I propanil, compound of formula I propazine, compound of formula I propaquizafop, compound of formula I propyzamide, compound of formula I prosulfuron, compound of formula I pyrazolynate, compound of formula I pyrazosulfuron-ethyl, compound of formula I pyrazoxyphen, compound of formula I pyridate, compound of formula I pyriminobacmethyl, compound of formula I pyrithiobac-sodium, compound of formula I quinclorac, compound of formula I quizalofop, compound of formula I rimsulfuron, compound of formula I sequestrene, compound of formula I sethoxydim, compound of formula I simetryn, compound of formula I simazine, compound of formula I sulcotrione, compound of formula I sulfosate, compound of formula I sulfosulfuron-methyl, compound of formula I tebutam, compound of formula I tebuthiuron, compound of formula I terbacil, compound of formula I terbumeton, compound of formula I terbuthylazine, compound of formula I terbutryn, compound of formula I thiazafluron, compound of formula I thiazopyr, compound of formula I thifensulfuron-methyl, compound of formula I thiobencarb, compound of formula I tralkoxydim, compound of formula I triallate, compound of formula I triasulfuron, compound of formula I trifluralin, compound of formula I tribenuron-methyl, compound of formula I triclopyr, compound of formula I triflusulfuron, and compound of formula I trinexapac-ethyl, and esters and salts of those mixing partners for the compound of formula I that are mentioned e.g. in The Pesticide Manual, Eleventh Edition, 1997, BCPC.
P.OPER\MaKl7056-99 sp.doc-27/06/OI 131A- The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that that prior art forms part of the common general knowledge in Australia.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" and "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
o.
*oooo
Claims (7)
1. A compound of formula I R 1 X, R 3 wherein R, is hydrogen, fluorine, chlorine, bromine or methyl; R 2 is CV-C 4 alkyI, C 1 -C 4 haloalkyl, halogen, nitro, amino, cyano or R 43 is hydrogen, Cl-C 8 a[ky, C 3 -Cealkenyl, C 3 -C~alkynyl, C 3 -C 6 cycloalkyl, Cl-Cahaloalkyl, cyano-Cl-CealkyI, C 3 -C~haloalkenyl, hydroxy-C 1 -C 4 a~kyI, C 1 -C 4 alkoxy-C 1 -C 4 alkyI, C 3 -C 6 alkenyloxy-Cl-C 4 alkyI, C 3 -C 6 alkynyloxy-C 1 -C 4 alkyl, C 1 -C 4 alkoxy-Cl-C 4 alkoxy-C 1 -C 4 -alkyl, :11: C 1 -C 4 alkylthio-C 1 -C 4 alkyl, C 1 -C 8 alkylcarbonyl, Cl-C~alkoxycarbonyl, C 3 -Coalkenyl- oxycarbonyl, benzyloxy-C 1 or -C 2 -alkyl, benzylcarbonyl, benzyloxycarbonyl, phenyl, phenyl-C 2 -Caalkyl, benzyl, pyridyl, pyrimidinyl, pyrazinyl or pyridazinyl, those aromatic and heteroaromatic rings being unsubstituted or mono- to tri-substituted by halogen, C 1 -C~alkyI or by Cl-C 4 haloalkyl; or R44X 16 C(O) -[C 1 -C~alkylene)- R 43 is R44X 16 C(O)-Cj-C 8 alkyI- or I (C 6 H 5 X1 6 is oxygen, sulfur or RN .R44 is hydrogen, C 1 -Cealkyl, C 3 -C~alkenyl, C 3 -Caalkynyl, C 3 -C 6 cycloalkyl, C 1 -C 8 haloalkyl, 0 3 -C 8 haloalkenyl, C 1 -C 4 alkoxy-Cl-C 4 alkyl, C 3 -C 6 alkenyloxy-C 1 -C 4 alkyl, C 1 -C 4 alkylthio-C, C 4 alkyl, phenyl, phenyl mono- to tri-substituted by halogen, C 1 -C 4 alkyI or by Cl-C 4 -halo- alkyl, benzyl or benzyl mono- to tni-substituted on the phenyl ring by halogen, C 1 -C 4 alkyl or by C 1 -C 4 haloalkyl; R 45 is hydrogen, C 1 -C 8 alkyl, C 3 -C 8 alkenyl, C 3 -C~alkynyl, C 3 -C 6 CYCloalkyl, Cl-C 8 haloalkyl or benzyl; )N~LS WO 99/52893 PCT/EP99/02313 -133- R 3 is hydroxy, Cl -C 6 alkoxy, C 3 -C 6 alkenyloxy, C 3 -C 6 alIkynyloxy, C 1 -C 6 haloalkoxy, C 3 -C 6 haloalkenyloxy, C, -C~alkoxy-0 1 -C~alkyl, C 3 -C 6 alkenyloxy-C, -C 6 atkyl, C 3 -C 6 alkynytoxy- Cl-C 6 alkyI, Cl-C 6 alkoxy-Cl-C 6 alkoxy-C 1 -C 6 alkyI, B 1 -C 1 -C 6 alkoxy, R 4 Cl -C 6 alkyI, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, C 2 -C 6 haloalkyl, C 3 -C 6 haloalkenyl, C 3 -C 6 CYCloalkyl, C 3 -C 6 halocycloalkyl, 1 -C 1 -C~akyl, OHO-, Cl-C 6 alkylcarbonyl, C 1 -C 6 alkylcarbonyloxy, -C 6 haloalkylcarbonyl, 0 2 -C 6 alkenylcarbonyl, Cl-C 6 alkoxycarbonyl, Cl-C 6 alkyl-S(O) 2 Cl -C 6 haloalkyl-S(O) 2 C 3 -C~trialkylsilyloxy, (Cl-C 6 alkyl) 2 N-N=CH-, CH 2 C 1 -C 3 alkyI Bl-CH=N-, (CH 3 2 N-CH=N-, (C 1 -C 5 hydroxyalkyl)-CH 2 (B 1 -C 1 CH- hydroxyalkyl)-CH 2 (Bj-C 1 -C 5 haloalkyl)-CH 2 (hydroxy-C 1 -C 5 alkyI)-O- or (B 1 hydroxyalkyl)-O-;, B 1 is cyano, OHO-, HOC(O)-, Cl-C 6 alkylcarbonyl, Cl-C 6 haloalkycarbonyl, C 1 -C 6 alkoxy- carbonyl, C 3 -C 6 alkenyloxycarbonyl, C 3 -C 6 alkynyloxycarbonyl, benzyloxy, benzyloxy- carbonyl, benzyloxycarbonyl mono- to tni-substituted on the phenyl ring by halogen, C 1 -C 4 alkyI or by Cl -C 4 haloalkyl, benzylthio, benzylthiocarbonyl, benzylthiocarbonyl mono- to tni-substituted on the phenyl ring by halogen, C 1 -C 4 alkyl or by C, -C 4 haloalkyl, Cl-C 6 haloalkoxycarbonyl, C 1 -C 6 alkylthio-C(O)-, R 6 (R 7 phenyl, phenyl mono- to tni-substituted by halogen, C1-C 4 alkyI or by Cl-C 4 haloalkyl, C 1 -C 6 alkyl-S(O) 2 0,-C 6 alkyl-S(O)-, 01 -C 6 al kylthio-, C 3 -C 6 CYCloalkyl, C 1 -C 6 alkoxy, C 3 -C 6 alkenylthio or 0 3 -C 6 alkynylthio; R 4 and R 5 are each independently of the other hydrogen, Cl-C 6 alkyl, C 3 -C 6 alkenyl, C3-C6- alkynyl, Cl,-C 6 haloalkyl, C 3 -C 6 haloalkenyl, C 3 -C 6 CYCloalkyl, CI-C~akoxy-C.,-C~alkyl, OHC-, Cl-C 6 alkylcarbonyl, Cl-C 6 haloalkylcarbonyl, Cl-C 6 alkyl-S(O) 2 or C.,-C 6 haloalkyl- R 6 and R 7 are each independently of the other hydrogen, Cl-C 6 alkyl, C 3 -C 6 alkenyl, C3-C6- alkynyl, C.,-C 6 haloalkyl, 0 3 -C 6 haloalkenyl, phenyl, phenyl mono- to th-substituted by halogen, C.,-C 4 alkyl or by 0 1 -C 4 haloalkyl, benzyl or benzyl mono- to tri-substituted on the phenyl ring by halogen, C1-C 4 alkyl or by Cl-C 4 haloalkyl; X, is oxygen or sulfur; WO 99/52893 PCT/EP99/023 13 134 R R9 R1 W is a group 13i) I'W) N (W 3 1 X 3 N X 2 X 4 N" R 1 R 21 R 20 R2 26 R 2 (W) X 6 N NR24~ NN R 17 X 8 N X71 I I R8 R 27 R 3 0 F R 31 (W8) N- (WE or (W 10 113 14 R 8 is Cl-C 3 alkyl, Cl-C 3 haloalkyl or amino; R 9 is 0 1 -C 3 haloalkyl, Cl-C 3 alkyl-S(Q)nl, Cl-C 3 haloalky-S(O)n.,or cyano; or R8 and R 9 together form a C 3 or 0 4 -alkylene bridge or 03- or C 4 -alkenylene bridge, each of which may be substituted by halogen, Cl-C 3 haloalkyl or by cyano; nj isO0,l1or 2; Rj 0 is hydrogen, C 1 -C 3 alkyI, halogen, Cl-C 3 haloalkyl or cyano; or Rio and R 9 together form a 03- or C 4 -alkylene bridge or C3- Or C 4 -alkenylene bridge, each of which may be substituted by halogen, Cl-C 3 haloalkyl or by cyano; R 11 is hydrogen, C 1 -C 3 alkyl, halogen or cyano; R 12 is Cl-C 3 haloalkyl; R 12 and R 1 1 together form a C3- or 0 4 -alkylene bridge or C3- or C 4 -alkenylene bridge; R 13 is hydrogen, C 1 -C 3 alkyl or halogen; R 13 and R 1 2 together form a 03- or C 4 -alkylene bridge or C3- or C 4 -alkenylene bridge; R 14 is hydrogen, Cl-C 3 alkyI, halogen, C 1 -C 3 haloalkyl, R 33 R34S(O)n 2 RA 5 RA 6 N, R 38 (R 39 )N-C(R 37 hydroxy, nitro or NEC-S-; R 33 is Cl-C 3 alkyl, Cl-C 3 haloalkyl, C 2 -C 4 alkenyl, 03- or C 4 -alkynyl or Cl-C. 5 alkoxycarbonyl- Cl -C 4 alkyl; WO 99/52893 PCT/EP99/02313 -135- R34 is 0 1 -C 4 alkyl or Cl-C 4 haloalkyl; nl 2 isO0,l1or 2; R 35 is hydrogen, Cl-C 4 alkyl, Cl-C 4 haloalkyl, 0 3 -C 6 CYCloalkyl, OHO- or 0 1 -C 4 alkylcarbonyl; R 36 R 37 and R 39 are each independently of the others hydrogen or Cl-C 4 alkyl; R 38 is Cl-C 4 alkyl; R1 5 is hydrogen, 0 1 -C 4 alkyl, halogen, Cl-C 4 haloalkyl, C 2 -C 4 alkenyl, C 3 -C 5 haloalkenyl, C 3 or C 4 -alkynyl, C 1 -C 4 alkoxy, Cl-C 4 alkylcarbonyl, Cl -C 4 haloalkylcarbonyl, C 2 -C 4 alkenyl- carbonyl, C 2 -C 4 haloalkenylcarbonyl, C 2 -C 4 alkynylcarbonyl, C 2 -C 4 haloalkynylcarbonyl, C 1 -C 4 alkoxycarbonyl, Cl-C 4 alkylcarbamoyl, Cl-C 4 alkylS(0),, 3 C 3 or C 4 -alkynylS(O),, 3 OHC-, nitro, amino, cyano or N-E'C-S- n 3 isO0, 1 or 2; R 16 and R 17 are each independently of the other hydrogen, Cl-C 4 alkyl, halogen, C 1 -C 4 halo- alkyl or cyano; R 18 and R 19 are each independently of the other hydrogen, methyl, halogen, hydroxy or =0; R 20 and R 2 1 are each independently of the other hydrogen, Cl-C 4 alkyl or Cl-C 4 haloalkyl; R 22 and R 23 are each independently of the other hydrogen, Cl-C 3 alky, halogen or hydroxy; R 24 and R 25 are each independently of the other hydrogen or CI-C 4 alkyl; or /,4 R 24 and R 25 together form the group =C, R 40 and R 41 are each independently of the other Cl-C 4 alkyl; or R 40 and R 41 together form a C 4 or C 5 -alkylene bridge; R 26 is hydrogen or Cl-C 3 alkyl; or R 26 together with R 25 forms a C 3 -C 5 alkylene bridge, which may be interrupted by oxygen and/or substituted by halogen, Cl-C 4 alkyl, C 2 -C 4 alkenyl, CI-C 3 haloalkyl, C 1 -C 3 alkyl- carbonyloxy, CI-C 4 alkoxycarbonyl, Cl-C~alkyisultonyloxy, hydroxy or by =0; R 27 R 28 R 29 and R 30 are each independently of the others hydrogen, Cl-C 3 alkyI, C 3 or 04- alkenyl or C 3 -C 5 alkynyl; or R 27 and R 28 together and/or R 29 and R 30 together in each case form a C 2 -C 5 alkylene bridge or C 3 -C 5 alkenylene bridge, each of which may be interrupted by oxygen, sulfur or S(0) 2 and/or substituted by halogen, CI -C 4 alkyl, C 2 -C 4 alkenyl, CI -C 3 alkylcarbonyloxy, C 1 -C 3 alkylsulfonyloxy, hydroxy or by =0; WO 99/52893 PCT/EP99/02313 136 R 31 is hydrogen, Cl-C 4 alkyl, Cl-C 4 haloalkyl, C3- or C 4 -alkenyl, C3- or C 4 -hafoalkenyl or C3- or C 4 -alkynyl; R 32 is hydrogen, 0 1 -C 4 alkyl, C 1 -C 3 alkoxy-C 1 or -0 2 -alkyl, C 1 -C 4 haloalkyl, C3- or 0 4 -alkenyl,
03- or 0 4 -haloalkenyl or C3- or 0 4 -alkynyl; or R 32 and R 31 together form a 0 3 -C 5 alkylene bridge; and X 2 X 3 X 4 X 5 X 6 X 7 X 8 X 9 X1 0 X 1 I, X 12 X 13 X 14 and X 1 5 are each independently of the others oxygen or sulfur, or an agrochemically acceptable salt or stereoisomer of such a compound of formula 1. 2. A compound according to claim 1 of formula 'w N X 1 R3 wherein R, is hydrogen, fluorine, chlorine, bromine or methyl; R 2 is methyl, halogen, hydroxy, nitro, amino or cyano; and R 3 X, and W are as defined in claim 1. 3. A process for the preparation of a compound of formula I N wherein RI, R 2 and W are as defined in claim 1; X, is 0 or S; R 3 is 0 1 -C~alkoxy-C 1 -C~alkyl, C 1 -C 6 alkoxy-0 1 -C 6 alkoxy-C 1 -C~alkyl, CI -C 6 alkyl, C 3 -C 6 alkenyl, C 3 -C 6 alkynyl, C 2 -C 6 haloalkyl, C 3 -C 6 haloalkenyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, B 1 -C 1 -C 6 alkyl, '7.-CH 2 0 WO 99/52893 PCT/EP99/02313 -137- O C 1 -C 3 alky l (C 1 -Cshydroxyalkyl)-CH 2 (B 1 -C 1 -Cshydroxyalkyl)-CH 2 or CH,-- (B,-C 1 -C 5 haloalkyl)-CH 2 and B 1 is as defined in claim 1, which process comprises oxidising a compound of formula III R, R 2 W (1) N in a suitable solvent to form a compound of formula V R1 R 2 1W (V) 0- and then rearranging that compound in an inert solvent in the presence of an anhydride or in the presence of antimony pentachloride to yield, after aqueous working-up, a compound of formula II R1 R2- W (II), N OH the radicals R 1 R 2 and W in the compounds of formulae II, III and V being as defined, and then alkylating that compound in the presence of an inert solvent and a base with a com- pound of formula VI R 3 -L (VI), wherein Ra is as defined and L is a leaving group, in a suitable inert solvent and a base to form the compounds of formulae I and IV R, R, R 'W and R 2 W (IV), N N X, R, OR3 -138- wherein R 1 R 2 R 3 and W are as defined and X 1 is 0, and then, after the compound of formula I has been separated from the pyridol derivative of formula IV, optionally functionalising the pyridono derivative of formula I further in accordance with the definitions of X 1 and R 3
4. A compound of formula II Ri R I R2W R (11), N NH OH O wherein R 1 R 2 and W are as defined in claim 1. A herbicidal and plant-growth-inhibiting composition, comprising a herbicidally effective amount of a compound of formula I on an inert carrier.
6. A herbicidal and plant-growth-inhibiting composition according to claim 5, comprising at least one further co-herbicide as additional component.
7. A method of controlling undesired plant growth, which method comprises applying a compound of formula I, or a composition comprising such a compound, in a herbicidally effective amount to plants or to the locus thereof.
8. Use of a composition according to claim 5 in the control of undesired plant growth.
9. A compound of formula I according to claim 1, substantially as hereinbefore described with reference to the Examples. 9 o DATED this 28th day of June, 2001 Novartis AG By DAVIES COLLISON CAVE Patent Attorneys for the Applicants
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH840/98 | 1998-04-08 | ||
| CH84098 | 1998-04-08 | ||
| PCT/EP1999/002313 WO1999052893A1 (en) | 1998-04-08 | 1999-04-06 | N-pyridonyl herbicides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3705699A AU3705699A (en) | 1999-11-01 |
| AU738222B2 true AU738222B2 (en) | 2001-09-13 |
Family
ID=4196437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU37056/99A Ceased AU738222B2 (en) | 1998-04-08 | 1999-04-06 | N-pyridonyl herbicides |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1076655A1 (en) |
| JP (1) | JP2002511461A (en) |
| KR (1) | KR20010042521A (en) |
| CN (1) | CN1295570A (en) |
| AU (1) | AU738222B2 (en) |
| BR (1) | BR9909487A (en) |
| ID (1) | ID27165A (en) |
| WO (1) | WO1999052893A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| WO2003059884A1 (en) | 2001-12-21 | 2003-07-24 | X-Ceptor Therapeutics, Inc. | Modulators of lxr |
| AP1822A (en) | 2002-02-14 | 2008-01-30 | Pharmacia Corp | Substituted pyridinones as modulators of P38 MAP kinase. |
| KR100574350B1 (en) * | 2004-08-31 | 2006-04-27 | 한국화학연구원 | Process for preparation of 2-aminopyridine derivatives |
| NZ566799A (en) | 2005-09-14 | 2011-04-29 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors for treating diabetes |
| TWI417095B (en) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| EA017648B1 (en) | 2007-09-14 | 2013-02-28 | Орто-Макнейл-Янссен Фармасьютикалз, Инк. | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |
| US8691849B2 (en) | 2008-09-02 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| US8691813B2 (en) | 2008-11-28 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| MY153912A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 1, 2, 4,-triazolo[4,3-a[pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| BRPI1012870B8 (en) | 2009-05-12 | 2021-05-25 | Addex Pharmaceuticals Sa | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors and pharmaceutical composition |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| JP5852666B2 (en) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor |
| US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| CA2814998C (en) | 2010-11-08 | 2019-10-29 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| WO2014004094A1 (en) * | 2012-06-30 | 2014-01-03 | Dow Agrosciences Llc | Production of n-substituted sulfoximine pyridine n-oxides |
| JO3368B1 (en) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| JO3367B1 (en) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| SI3431106T1 (en) | 2014-01-21 | 2021-03-31 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use |
| UA121965C2 (en) | 2014-01-21 | 2020-08-25 | Янссен Фармацевтика Нв | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58213776A (en) * | 1982-06-07 | 1983-12-12 | Ishihara Sangyo Kaisha Ltd | Pyridazinone compound and fungicide containing the same |
| JPS62258731A (en) * | 1986-05-06 | 1987-11-11 | Kao Corp | Oil-in-water-type emulsified composition |
| DE3917469A1 (en) * | 1989-05-30 | 1990-12-06 | Bayer Ag | Heterocyclyl-substd. pyridine derivs. - useful as herbicides, e.g. defoliants, desiccants and esp. weed-killers |
| NO179282C (en) * | 1991-01-18 | 1996-09-11 | Rhone Poulenc Agrochimie | New 1- (2-pyridyl) pyrazole compounds for control of insect pests |
| US5726124A (en) * | 1992-07-17 | 1998-03-10 | Rohm And Haas Company | 2-arylpyrimidines and herbicidal use thereof |
| JPH06172306A (en) * | 1992-10-05 | 1994-06-21 | Nissan Chem Ind Ltd | Cyclic amide compound and herbicide |
| DE19518054A1 (en) * | 1995-03-08 | 1996-09-12 | Hoechst Schering Agrevo Gmbh | New 1-(phenyl or pyridyl)-pyrazole derivs. |
| DE19530606A1 (en) * | 1995-08-21 | 1997-02-27 | Basf Ag | 1- (pyridyl) pyrazole |
| GB9711753D0 (en) * | 1997-06-06 | 1997-08-06 | Merck Sharp & Dohme | Therapeutic agents |
-
1999
- 1999-04-06 BR BR9909487-8A patent/BR9909487A/en not_active IP Right Cessation
- 1999-04-06 JP JP2000543452A patent/JP2002511461A/en active Pending
- 1999-04-06 ID IDW20002021A patent/ID27165A/en unknown
- 1999-04-06 KR KR1020007011155A patent/KR20010042521A/en not_active Application Discontinuation
- 1999-04-06 CN CN99804531A patent/CN1295570A/en active Pending
- 1999-04-06 WO PCT/EP1999/002313 patent/WO1999052893A1/en not_active Application Discontinuation
- 1999-04-06 AU AU37056/99A patent/AU738222B2/en not_active Ceased
- 1999-04-06 EP EP99919194A patent/EP1076655A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010042521A (en) | 2001-05-25 |
| JP2002511461A (en) | 2002-04-16 |
| AU3705699A (en) | 1999-11-01 |
| CN1295570A (en) | 2001-05-16 |
| EP1076655A1 (en) | 2001-02-21 |
| ID27165A (en) | 2001-03-08 |
| BR9909487A (en) | 2000-12-12 |
| WO1999052893A1 (en) | 1999-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU738222B2 (en) | N-pyridonyl herbicides | |
| US6274536B1 (en) | Pyrazole derivatives as herbicides | |
| RU2246492C2 (en) | Intermediate compounds for preparing derivatives of 3-hydroxy-4-aryl-5-oxopyrazoline showing herbicide effect | |
| WO2004035563A1 (en) | 3-heterocyclylpyridine derivatives useful as herbicides | |
| ES2200927T3 (en) | HERBICIDE COMPOSITION. | |
| EP1250047B9 (en) | Herbicidal composition | |
| ES2233451T3 (en) | NEW HERBICIDES. | |
| WO2004035564A1 (en) | Pyridine derivatives useful as herbicides | |
| US20040102325A1 (en) | Phenylpropynyloxypyridine herbicides | |
| US6380134B1 (en) | N-pyridyl herbicide compounds | |
| US6369002B1 (en) | N-heteroaryl-substituted pyridine derivatives and their use as herbicides | |
| US5710278A (en) | Herbicidal 1-pyridyltetrazolinones | |
| WO2001030782A2 (en) | Novel herbicides | |
| AU2003276976B2 (en) | Nicotinoyl derivatives as herbicidal compounds | |
| AU732154B2 (en) | Benzothiophene derivates as herbicides | |
| WO2001066522A1 (en) | Acylated phenyl or pyridine herbicides | |
| WO2002024704A1 (en) | Novel herbicides | |
| WO2002024709A2 (en) | Bicycloderivatives as herbicides | |
| DE3929170A1 (en) | N- (5-ALKYLTHIOPHENYL) NITROGEN HETEROCYCLEN | |
| US5133798A (en) | Certain herbicidal 1,2,4-triazolo[4,5-b]pyridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |